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 Abstract 
The peripheral nerves that communicate skin, muscle and sensory organs with the brain 
must maintain functionality throughout life despite frequent stress and injury. Loss of 
integrity of peripheral neurons and associated glial cells is a common occurrence in severe 
neurological dysfunctions that include weakness, pain and loss of sensation. Therefore, 
protecting the nervous system from chronic effects of physical and chemical stress is a 
pressing clinical challenge. This has sparked intense efforts to exploit molecular inhibitors 
of axonal and glial destruction. Loss of function of the obligate pro-degenerative protein 
Sarm1 blocks axon degeneration across species. Thus, Sarm1 is an ideal target for clinical 
application aimed at reducing axonal degradation in humans. In my thesis, I addressed the 
impact of Sarm1 deficiency on the development of the peripheral nervous system and glial 
Schwann cells. Using zebrafish, I show that elimination of Sarm1 is compatible with neural 
homeostasis, and is glioprotective against chemotherapeutic agents after nerve injury. 
Specifically, I have discovered that Schwann cells are not essential for the maintenance of 
severed axons lacking Sarm1, which subsist well beyond the normal timeframe allowed by 
Sarm1 destructive activity. Moreover, in Sarm1-deficient animals, the axons that 
regenerate after nerve injury regain connectivity with peripheral synaptic targets to enable 
sensorimotor recovery, revealing that neural-circuit repair is not contingent upon the 
clearance of damaged axons. In addition, I discovered that the loss of Sarm1 increases 
Schwann-cell resistance to toxicity by diverse chemotherapeutic agents after nerve injury. 
Overall, my findings indicate that pharmacological interventions targeting Sarm1 are 
promising strategies to reduce chronic consequences of nerve injury. 
 
 
 
 
 
 Abstrakt 
Die peripheren Nerven, die Haut, Muskeln und Sinnesorgane mit dem Gehirn verbinden, 
müssen trotz häufigem Stress und Verletzung lebenslang funktionsfähig bleiben. Der 
Verlust der Integrität von peripheren Neuronen und assoziierten Zellen, einschließlich 
Glia, tritt häufig bei schweren neurologischen Funktionsstörungen auf, zu denen 
Schwäche, Schmerzen und Sensibilitätsverlust gehören. Daher ist der Schutz des 
Nervensystems vor chronischen Auswirkungen von physischem und chemischem Stress 
eine dringende klinische Herausforderung. Dies hat intensive Bemühungen ausgelöst, 
molekulare Inhibitoren der axonalen und glialen Zerstörung einzusetzen. Der 
Funktionsverlust des pro-degenerativen Proteins Sarm1 blockiert Axondegeneration 
sowohl in Invertebraten als auch in Vertebraten. Somit ist Sarm1 ein ideales Ziel für die 
klinische Anwendung, um den axonalen Abbau beim Menschen zu verhindern. In dieser 
Arbeit untersuchte ich die Auswirkungen von Sarm1-Mangel auf die Entwicklung des 
peripheren Nervensystems und der Schwannschen Gliazellen. Im Zebrafisch 
Modellorganismus zeigte ich, dass die genetische Ausschaltung von Sarm1 mit der 
neuralen Homöostase vereinbar ist und gegen chemotherapeutische Wirkstoffe nach 
Nervenverletzungen glioprotektiv ist. Insbesondere habe ich herausgefunden, dass 
Schwann-Zellen, die nach Axonenabtrennung eliminiert werden, aber in Abwesenheit von 
Sarm1 bestehen bleiben, für die Aufrechterhaltung der abgetrennten Axonen nicht 
wesentlich sind. Darüber hinaus stellen die Axone, die sich nach einer Nervenverletzung 
regenerieren, beim Sarm1-defizienten Zebrafisch die Konnektivität mit peripheren 
synaptischen Zielen wieder her, um die Wiederherstellung der Sensomotorik mus zu 
ermöglichen. Außerdem entdeckte ich, dass der Verlust von Sarm1 die Toxizitätsresistenz 
von Schwann-Zellen durch verschiedene Chemotherapeutika nach einer Nervenverletzung 
erhöht. Insgesamt weisen meine Ergebnisse darauf hin, dass pharmakologische 
Interventionen gegen Sarm1 vielversprechende Strategien zur Verringerung der 
chronischen Folgen von Nervenverletzungen darstellen. 
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1. Introduction 
1.1 Zebrafish as a vertebrate model to study developmental neuroscience 
and neurological disorders 
The zebrafish (Danio rerio) is a small tropical freshwater fish, which has been used for 
scientific research since the 1980s (Streisinger et al., 1989; Streisinger et al., 1981). This 
vertebrate is easy and cheap to maintain. It is translucent, has an external embryonic 
development, breeds year-round and is amenable to genetic modifications. These 
advantages have made the zebrafish a powerful experimental system.  
The embryonic development of zebrafish, from the fertilized egg to the complete fish, is 
quite rapid. Briefly, after fertilization, the egg undergoes the following stages: Zygote 
Period (0-0.75 h), Cleavage Period (0.75-2.25 h), Blastula Period (2.25-5.25 h), Gastrula 
Period (5.25-10.33 h), Segmentation Period (10.33-24 h), Pharyngula Period (24-48 h), 
Hatching Period (48-72 h), and Larval Period (72 h-30 d) (Table 1.1). During this early 
development, the embryo is visually accessible because of the transparent membrane and 
cells. This allows researchers to observe the developmental process from one cell-stage to 
the free-swimming larva with the high-resolution microscopy.  
In the zebrafish larva, all the major organ systems, such as the nervous system, the 
cardiovascular system, the hematopoietic system, and the immune system are functional at 
5 dpf (days post fertilization). In addition, the abundance of offspring provides an 
advantage for genetic mapping and phenotype screening. Normally, one female fish can 
lay 100-200 eggs per mating and the fish can breed weekly. The zebrafish shares 
approximately 70 percent of genes with mammals as shown by genome sequencing (Buggs 
et al., 2012; Howe et al., 2013). It bridges the gap between invertebrate and mammalian 
model systems for studies, such as development, neuronal circuits, and behavior. 
Moreover, most of the cellular and physiological mechanisms of organs in zebrafish and 
mammals are conserved (Hsu et al., 2007; Williams and Hong, 2011). 
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Table 1.1 The development of zebrafish. The information is from Stages of embryonic development 
of the zebrafish, Kimmel CB, 1995. 
1.1.1 Genetic modification of zebrafish 
The Tol2 and Sleeping Beauty transposon systems enable scientists to generate transgenic 
lines easily. Combine with the UAS-GAL4 and Cre-loxP recombinases systems, 
researchers can obtain the specific fluorescence labeling transgenic or conditional gene 
modification lines (Kawakami, 2007; Kwan et al., 2007; Yant et al., 2005).  
To generate loss of function mutants or insert nucleotides/sequences in zebrafish, ZFN 
(zinc finger nucleases), TALEN (transcription activator-like effector nucleases), or 
CRISPR (clustered regularly interspaced short palindromic repeats) are widely used. The 
efficiency of the tools for gene editing dependents on their nuclease activity and cell 
autonomous repair pathways, such as non-homologous end-joining pathway (NHEJ) or 
homology-directed repair (HR). The difference of these nucleases is the way to recognize 
the specific site of the gene. ZFN and TALEN have a DNA binding domain which is used 
to recognize the interested gene, and a nuclease domain that introduces a double-strand 
DNA break at the location where the DNA binding domain is targeting (Doyon et al., 2008; 
Miller et al., 2011; Sander et al., 2011; Urnov et al., 2005). For CRISPR/Cas9, the single 
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guide RNA (sgRNA) works together with Cas9 nuclease to modify the DNA. The single 
guide RNA consists of a targeting sequence (crRNA: CRISPR RNA) to recognize the gene 
of interest and a Cas9 nuclease-recruiting sequence (tracrRNA: trans-activating crRNA) to 
allow Cas9 binding. When the crRNA recognizes the targeting site, the crRNA part recruits 
Cas9 protein to the site to cleave the DNA sequence (Cong et al., 2013; Hwang et al., 2013). 
In the DNA repair stage, these three genome-modify tools share the same double-strand 
DNA break repair mechanisms, the homology or non-homology mediated repairs. Both of 
these two repair ways are cell autonomous (Gaj et al., 2013; Wyman and Kanaar, 2006). 
During the DNA repair, some nucleotides are deleted or inserted randomly, which 
introduces a frameshift to generate a gene knockout line; the simultaneously injected 
oligonucleotides or short linearized double strand sequences are incorporated into the site 
of DNA break, which introduces the knock-in line (Chang et al., 2013; Li et al., 2016; 
Moehle et al., 2007; Ota et al., 2014; Varshney et al., 2015) (Figure 1.1). 
  
Figure 1.1 Schematic of the genetic methods used in zebrafish research. A)mRNA, ZFN, TALEN 
and CRISPR are used to modify the gene expression in zebrafish by injection into the one-cell stage 
embryos. For stable knockout or knock-in lines, the F0 founder fish from ZFN, TALEN and CRISPR is 
crossed to obtain the F1 stable transgenic line; B) Schematic picture showing the mechanism of how 
ZFN, TALEN and CRISPR work for knockout or knockin the genes. The designed constructs or RNAs 
are injected into the one-cell stage embryos. The nucleases break the genome DNA in the target sites, 
then the NHEJ or HR enables generation of knockout lines by deletion, insertion or substitution of the 
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nucleotides in the break site, and to make knockin lines by recombination the donor oligonucleotides or 
constructs. 
1.1.2 Zebrafish as a model for neuroscience and neurological disorders research 
Zebrafish has similar subdivisions of the nervous system as mammals, including the 
forebrain, midbrain, hindbrain, and spinal cord, which are formed in around 1 dpf larva. 
And the thalamus, the optic tectum and the cerebellum of zebrafish share the structural 
homology with mammals (Kozol et al., 2016). Moreover, the neurons in each subdivision 
grow and extend their axonal tracts in a stereotyped pattern (Kimmel, 1993). More and 
more neurotransmitter-expressing neurons and glial cells have been identified in 2-4 dpf 
larval zebrafish because of similar gene expression pattern in the early development of 
zebrafish with mammals. For instance, the GABAergic and glutamatergic (Higashijima et 
al., 2004), monoaminergic (Guo et al., 1999), peptidergic (Kaslin et al., 2004) and glial 
cells (oligodendrocytes, Schwann cells and astrocytes) (Brösamle and Halpern, 2002; 
Kawai et al., 2001) are presented in the zebrafish larva. In addition, the anatomical 
organization of the central and peripheral nervous system is highly conserved from 
zebrafish to mammals (Mathur and Guo, 2010). Furthermore, the evidence shows that 
neural circuits controlling the basic behaviors in zebrafish, such as sleep, acoustic startle 
and arousal (Lovett-Barron et al., 2017; Prober et al., 2006; Schoonheim et al., 2010), are 
conserved between fish and mammals.  
Neurodevelopmental disorders have been investigated using zebrafish. For instance, 
amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), are caused by the 
genetic dysfunction of several ALS an FTD related genes in motor neurons, including 
SOD1, TARDBP, FUS, and C9orf72 (Armstrong and Drapeau, 2013; Ciura et al., 2013; 
Hewamadduma et al., 2013; Sakowski et al., 2012; Van Hoecke et al., 2012); autism 
spectrum disorders (ASD), impairs in social behavior and communication by disrupting 
the genes shank3, cntnap2, or dyrk1a (Hoffman et al., 2016; Kozol et al., 2016); epilepsy, 
is mimicked by scn1b or scn1a mutants (Baraban et al., 2013; Grone et al., 2016); 
intellectual disability, is from stx1b or trappc6b mutants (Marin-Valencia et al., 2018; 
Schubert et al., 2014) and schizophrenia, is from disc1, cntn4 or mapk2 mutants (De Rienzo 
et al., 2011; Fromer et al., 2016; Gusev et al., 2018). In addition, models of Parkinson’s 
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disease, Alzheimer’s disease and Huntington’s disease have been reported in zebrafish, 
including MPTP induced PD model and DJ-1, PINK1 knockdown (Anichtchik et al., 2008; 
Bretaud et al., 2007; Lam et al., 2005; McKinley et al., 2005), FTDP-17 mutant model of 
tauopathy (Tomasiewicz et al., 2002), and loss function of HTT in zebrafish (Miller et al., 
2005; Schiffer et al., 2007). 
In summary, the zebrafish is an optimal complement to mammals in studies of neuronal 
circuits and neurological disorders.  
1.2 Zebrafish lateral line (Sensory nerve system) 
The lateral line of zebrafish is a mechanosensory system, which comprises sensory organs, 
neuromasts and sensory neurons. A neuromast consists of the mechanosensory hair cells 
and surrounding support cells. Hair cells are named from the hair bundle, a 
mechanosensory organelle that enables hair cells with vectorial excitability. The sensory 
neurons innervate the hair cells in the neuromast. Lateral line detects changes of water flow 
and pressure gradients in the surrounding environment of the zebrafish. It is also involved 
in large variety of behaviors, including escape, prey detection, detecting and avoiding 
predators, sexual courtship, tracking hydrodynamic trails, and rheotaxis (Coombs and 
Conley, 1997; Dehnhardt et al., 2001; Oteiza et al., 2017; Stewart et al., 2013). 
Furthermore, lateral line can provide sensory feedback to control the movements of the 
body through afferent and efferent neurons (Akanyeti et al., 2016; Haehnel-Taguchi et al., 
2018). 
1.2.1 Lateral line development 
The lateral line has two separated systems, anterior lateral line system (ALL) and posterior 
lateral line system (pLL). The ALL comprises the neuromasts on the head and the 
ganglions which are located between eyes and ears. The pLL comprises a bundle of 
ganglions which are behind the ear and a line of neuromasts extending from head to tail 
(Gompel et al., 2001), which develops during the early embryogenesis, around 18 hpf 
(hours post fertilization), from bilateral cephalic placodes (Figure 1.2 A).  
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The growth of sensory neurites is derived from the primordium (pLLP) which is a cohesive 
cluster of cells and migrates toward the tail along the horizontal myoseptum under the skin, 
depositing groups of cells that become neuromasts. The migrating pLLP is a dynamic 
structure with 100 cells changing in behavior and morphology. The cells in the leading end 
with the mesenchymal morphology are flatter and displace the proto-neuromast to the 
trailing position. The trailing part seeds taller cell with apical and basal polarity, which 
form center-oriented epithelial rosettes with the columnar epithelial morphology, and 
become the central hair cell progenitor of the nascent proto-neuromast (Lecaudey et al., 
2008; Nechiporuk and Raible, 2008). In the maturation stage, the trailing end cells lose 
their cohesion to the primordium and are deposited to form the neuromasts by incorporating 
the stable epithelial rosette along the horizontal myoseptum. The rest of the cells are 
deposited as inter-neuromast cells in the migrating primordium and generate additional 
neuromasts to the zebrafish (Chitnis et al., 2012). Hair cells of the neuromast are created 
in pairs by division of progenitors, and sibling hair cells acquire opposing polarities which 
enables them to be stimulated by water flow from both directions. This functional bi-
directional polarity and sensitivity is parallel to the migration of the primordium along the 
larva rostral-caudal axis in development (López-Schier et al., 2004). As the primordium 
migrates, axons from the ganglion extend accompanying and are myelinated by the 
migrating glial cells (Brösamle and Halpern, 2002; Gilmour et al., 2004). In their 
development, the lateralis afferents project to the hindbrain with central axons and 
innervate neuromasts with peripheral axons. These bipolar neurons innervate the hair cells 
of neuromasts and connect them to the hindbrain to establish the lateral line sensory system 
(Chitnis et al., 2012; Metcalfe et al., 1985). 
The posterior lateral line locates superficially along the trunk of the zebrafish, which is 
formed and becomes functional at the early stage of development. A number of signaling 
systems regulates the development of the pLL. For instance, neurogenin-1 is involved in 
the pLL ganglion formation. Loss of ngn1 wipes out the ganglions in pLL, but it does not 
affect the formation of neuromasts (Andermann et al., 2002; López-Schier and Hudspeth, 
2005). Glial-derived neurotrophic factor (GDNF) functions as an attractive cue for axon 
migration (Schuster et al., 2010). The two chemokine receptors, cxcr4b and cxcr7b, with 
their ligand SDF1α (CXCL12), regulate the pattern of the anterior-posterior axis (Dambly-
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Chaudière et al., 2007; David et al., 2002; Valentin et al., 2007). Itcha and itchb influence 
the lateral line development by perturbing the expression pattern of cxcr4 and cxcr7, 
synchronizing with their function in regulating Wnt signaling pathway. In the itch 
knockdown larva, the failure to down regulate Wnt signaling and cxcr4b overexpression in 
primordium result in a slower migration of the pLL primordium and abnormal development 
of the lateral line (Angers and Drapeau, 2014). Moreover, the zinc-finger transcription 
factor, Insulinoma-associated 1 (Insm1), regulates the Wnt/β-catenin signaling, Fgf target 
genes, and chemokine signaling genes in the primordium. Loss of insm1a decreases the 
proliferation of primordium cells and reduces the number of hair cells in neuromasts (He 
et al., 2017). Hence, the development of lateral line is a highly organized process, enabling 
the sensory neurons to communicate with their innervating organs (Figure 1.2 B). 
 
Figure 1.2 The development of the lateral line system in zebrafish. A) Top panel shows the 7dpf 
larva with bright-field microscope and the whole lateral line neurons with green fluorescence protein 
label (The line: Tg[HGn39D]). Down panel shows the lateral line neurons (Green: Tg[HGn39D]) and 
sensory organs, neuromasts (Red: Tg[Brn3c-gal4; UAS-RFP]); B) shows the development of the lateral 
line. Top panel showing the 2dpf larva with the red ganglions and the brown primI (first primordium) 
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in the pLL; Middle panel showing the 4 dpf larva with primII (second primodium) and primD (dorsal 
primordium) and neuromasts in the pLL (posterial lateral line) ; the down panel showing the 7 dpf larva 
with developed lateral line (Pujol-Martí, J et al., 2013). 
1.2.2 Lateral line as a nerve regeneration model for research 
The superficially located posterior lateral line (pLL) has the ability to regenerate and to re-
innervate its targets (neuromasts) after injury, making the pLL an ideal model for 
investigating neuron degeneration and regeneration in vivo. Axon regeneration has been 
showed in the posterior lateral line in the Tg[HuC:GFP] larva. The extirpated axons 
regenerate and extend into the trunk, functionally innervating neuromasts within 24 hours 
(Grant et al., 2005). After axotomy, the distal axon undergoes Wallerian degeneration and 
the proximal nerve starts to regrow a few hours later. The robust regeneration begins when 
the axonal debris in the distal part have been cleared. 24 hours after axotomy, the axons 
regenerate completely to the tip of the tail without difference to the intact pLL in terms of 
structure and trajectory (Villegas et al., 2012). The transgenic line Tg[HGn39D], which 
labels the afferent neurons of the lateral line, dramatically improve the ability to record the 
dynamic events in development (Faucherre et al., 2009). Even in the adult fish, the pLL 
still has the capacity to regenerate after injury, in which the original branching pattern could 
be reproduced with the regeneration after axotomy. Thus, the pLL is a convenient in vivo 
system for studying axonal degeneration and regeneration (Graciarena et al., 2014).  
1.3 Neuron degeneration and regeneration 
In both vertebrate and invertebrate, the peripheral nerves can regenerate functionally by 
regrowth of axons which reinnervate their target cells after injury. In mammals, the central 
nervous system has lost the capacity to regenerate after trauma; however, zebrafish can 
regenerate injured central nerves (Alunni and Bally-Cuif, 2016).  
1.3.1 Axon degeneration (Wallerian degeneration) 
Axonal degeneration occurs during normal neuron development, pathology of 
neurodegenerative disorders and nerve damage. After injury, there are two types of axonal 
degeneration with the damaged axons, acute axonal degeneration (AAD) and Wallerian 
degeneration (WD) (Knöferle et al., 2010; Waller, 1850).  
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AAD occurs in minutes following severing, which causes short-distance axonal 
fragmentation in both the proximal and the distal axonal stumps and leads to retraction of 
the proximal axonal stump. After AAD, distal portions of the severed axons are in the first 
stage of WD, called the latent phase. This phase lasts one or two days in the severed nerve 
in mouse, or 2-6 hours in zebrafish. Then, the severed axons undergo the initiation phase 
and degenerate quickly upon axon fragmentation, neurofilaments breakdown, swelling of 
mitochondria in the execution phase. Finally, the debris is eradicated by phagocytes 
(Martin et al., 2010).  
WD is thought to be a protective response for nerve functional recovery from injury. It is 
a cellular degradation process and is different from apoptosis (Deckwerth and Johnson Jr, 
1994). In the initiation phase, the most important factors are NMNATs (nicotinamide 
mononucleotide adenylytransferases). They catalyse the production of NAD (Nicotinamide 
adenine dinucleotide), which affects the axonal degeneration. NAD involved in many 
biological reactions as a co-substrate of sirtuins, ADP (Adenosine diphosphate) 
polymerases, ADP transferase, and cyclin ADP-ribose processes (CD38). In vitro 
experiments show that the level of NAD significantly decreases around 3 or 4 hours post 
axotomy; however, the morphology of axons remains intact. The decline of NAD can be 
delayed by overexpression of NMNATs in the transected axons (Gerdts et al., 2015; Wang 
et al., 2005). In detail, NMNAT2 knockdown triggers intact axon degeneration, whereas 
other isoforms (NMNAT1/3) fail to compensate this process (Conforti et al., 2011; Gilley 
and Coleman, 2010; Yamamoto et al., 2016). New studies suggest that NMN (β-
nicotinamide mononucleotide) accumulation in the NMNAT2 null promotes axon 
degeneration after injury. FK866, an inhibitor of NAMPT (nicotinamide 
phosphoribosyltransferase) that catalyzes NAM to NMN, delays the axonal degeneration 
by decreasing the levels of NAD and NMN and accelerating the depletion of ATP (Di 
Stefano et al., 2015). NMN deamidase decreases NMN accumulation in injured nerves 
preserving the axons for three weeks. It also rescues the axonal outgrowth and death in the 
NMNAT2 null mice (Di Stefano et al., 2017; Loreto et al., 2015). Furthermore, Ca2+ influx 
is detected in distal axons after axotomy. In zebrafish, there are two waves of calcium 
influx during axon degeneration. The first wave occurs during axotomy. The second one 
takes place 4-6 hours later (Loreto et al., 2015; Vargas et al., 2015). In addition, Sarm1 
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(Sterile Alpha and TIR Motif containing 1) and DR6 (death receptor 6) have been reported 
in regulating of WD. Loss of Sarm1 blocks axon degeneration in fruit flies and mice 
(Osterloh et al., 2012). More details about Sarm1 in axon degeneration will be introduced 
in the following section (Section 1.5). The orphan receptor, DR6, promotes axon 
degeneration by JNK (C-Jun N-terminal kinases) signaling pathway in vitro and in vivo 
(Gamage et al., 2017). In the execution phase, calcium influx activates calpain to fragment 
the cytoskeleton in distal axons. The calpain inhibitors and methyl pyruvate can block the 
axonal fragmentation. Moreover, ATP depletion is upstream of calpain activation, because 
rescuing ATP depletion can block the calpain activation induced-fragmentation (Ma et al., 
2013; Yang et al., 2015a; Yang et al., 2013). During the axon degeneration, glia cells and 
macrophages are involved in clearing the axonal debris (Lyons and Talbot, 2015; Wang et 
al., 2012).  
In zebrafish, distal axons undergo three stereotyped phases of WD, lag phase, 
fragmentation phase, and clearance phase. The overexpression of Wlds or inhibitors of 
ubiquitylation dramatically elongates the lag phase, but do not influence the fragmentation 
(Martin et al., 2010). In the fragmentation phase, the Schwann cells and leukocytes regulate 
the amount of axon debris and the clearance process in the pLL (Villegas et al., 2012) 
(Figure 1.3 A & B).  
1.3.2 Axon regeneration  
Axon regeneration varies across species as well as in the central and peripheral nervous 
systems (CNS and PNS) in mammalians. In adult mammals, the injured CNS fails to repair 
and to rebuild the functional re-innervation of original targets, while the PNS retains the 
ability to recover functionally after injury. However, zebrafish possess the ability to restore 
the nerve functionally from injury in both central and peripheral nervous systems (Becker 
and Becker, 2014; Dias et al., 2012).  
The regenerative process requires orchestrating the intrinsic factors which include 
transcriptional factors, epigenetic modifier and protein regulation, as well as extrinsic 
events which include tissue repair, interaction with glia cells and immuno-response (Mahar 
and Cavalli, 2018). In regenerating axons, the injury activates several signal pathways to 
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promote axonal regeneration. For instance, the conversion of Na+/Ca2+ pumps enhances 
calcium influx after injury. The calcium wave is involved in axonal membrane resealing, 
mRNAs and proteins translocation, proteins synthesis, growth cone assembly, 
transcriptional factors regulation, and epigenetic modification (Bradke et al., 2012; Rishal 
and Fainzilber, 2014). In the injured axons, the calcium actives cAMP at the near side of 
injury to promote PKA activation. The activated PKA facilitates DLK (Dual leucine zipper 
kinase) activation to phosphorylate STAT3 (Signal transducer and activator of 
transcription 3) to activate the expression of pro-regeneration factors (Hao et al., 2016; 
Pérez-Cadahía et al., 2011; Shin et al., 2012). Simultaneously, STAT3 mRNA that is near 
the injury site of the axon is translated into protein which is phosphorylated by JAKs (Janus 
kinase) and MAPKKs (Mitogen-activated protein kinase kinases). The phosphorylated 
STAT3 forms strong interactions with stathmin, which inhibits the microtubule 
destabilizing activity of stathmin and promotes axon regeneration (Selvaraj et al., 2012; 
Verma et al., 2009). Moreover, the cytosolic ERK1 (Extracellular signal–regulated 
kinases) and ERK2 are activated by phosphorylation, and bind to vimentin and importin-β 
to promote retrograde transport (Perlson et al., 2005). The mammalian target of rapamycin 
(mTOR) is also a key factor for axon regeneration. Directly activating mTOR or deleting 
its upstream negative factors TSC1 (Tuberous sclerosis proteins 1), TSC2 and PTEN 
(Phosphatase and tensin homolog) increases the ability of injury axons to regenerate (Abe 
et al., 2010; Berry et al., 2016; Liu et al., 2010; Park et al., 2008). The transcription factors 
ATF3 (activating transcription factor 3) activated by cAMP and SMAD (Mothers Against 
Decapentaplegic Homolog ) activated by GSK3 (glycogen synthase kinase 3) or BMP2 
(Bone morphogenetic protein 2) or BMP4, promote axon growth in DRG (Dorsal root 
ganglion) neurons in vitro (Seijffers et al., 2007; Zou et al., 2009). In addition, more and 
more transcription factors, such as HIF1α (hypoxia inducible factor 1 subunit alpha), p53 
(tumor protein P53), SOX11 (Sex Determining Region Y – Box 11), MYC (MYC Proto-
oncogene, BHLH Transcription Factor) and SRF (Serum Response Factor), play roles in 
axon regeneration (Belin et al., 2015; Cho et al., 2015; Di Giovanni et al., 2006; 
Norsworthy et al., 2017; Stern et al., 2013). About the epigenetic dynamics in axon 
regeneration, the acetylation of histones by KAT2B (lysine acetyltransferase 2B) which is 
activated by ERK and their oxidization of 5mC to 5hmC by TET3 (Tet methylcytosine 
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dioxygenase), promotes the transcription of pro-regenerative genes (Puttagunta et al., 2014; 
Weng et al., 2016). Moreover, HDAC4 (Histone deacetylase 4) translocated from the 
nucleus deacetylates the microtubules at the injury site  increases the dynamic of growth 
cone and promotes axon growth (Chawla et al., 2003). In contrast to the pro-regenerative 
factors, there are some axon regeneration inhibitory molecules, such as RTCA (RNA 3’-
terminal phosphate cyclase A), RTCB (RNA 3’-terminal phosphate cyclase B), NogoA, 
MAG, CSPGs (chondroitin sulfate proteoglycan a), PARP1 (poly (ADP-ribose) 
polymerase), and myelin-derived Nogo (Brochier et al., 2015; Kosmaczewski et al., 2015; 
Mahar and Cavalli, 2018; Schwab and Strittmatter, 2014; Song et al., 2015; Yiu and He, 
2006)  (Figure 1.3 C).  
In zebrafish, a successful CNS regeneration combines a number of intrinsic and extrinsic 
factors allowing a functional recovery. For instance, ECM (extracellular matrix) 
components, CSPGs (chondroitin sulfate proteoglycans), form the scar to inhibit axon 
regrowth in mammals. But the CSPGs are not expressed in the lesion site in zebrafish optic 
nerve (Becker and Becker, 2002). The inhibitory molecule, NogoA, is shown missing the 
N-terminal inhibitory domain in zebrafish, which inhibits axon regeneration in mammals 
(Abdesselem et al., 2009). Additionally, zebrafish oligodendrocytes increase pro-
regeneration molecules expression, such as P0 (Schweitzer et al., 2003), L1-related 
molecules (Bernhardt et al., 1996) and contactins (Haenisch et al., 2005; Schweitzer et al., 
2007) after CNS injury; however, the oligodendrocytes in mammals do not.  
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Figure 1.3 The mechanisms of axon degeneration and regeneration after injury. A) & B) The injury 
axon undergoes the acute axonal degeneration (AAD) and Wallerian degeneration (WD) after injury. 
The AAD happens at the injury sites, where the axon is quickly fragmented and degrades. The WD 
consists three phases, latent phase with NAD and ATP loss, fragmentation phase with calcium influx 
and calpain induced cytoskeleton distruction and clearance phase with Schwann cells and macrophages 
engulf and clear the debris of axons; C) The network showing the signalling pathways and molecules 
are involved in axon regeneration by promoting the axon regrowth after injury and molecules which 
inhibit axon regeneration. NMNAT, nicotinamide mononucleotide adenylyltransferase; NAD, 
nicotinamide adenine dinucleotide; ATP, adenosine triphosphate; JAK, Janus kinase; MAPK, mitogen-
acticated protein kinase; STAT3, signal transducer and activator of transcription 3; DLK, dual leucine 
zipper kinase; PKA, protein kinase A; cAMP, cyclic adenosine monophosphate; ATF3, activating 
transcription factor 3; HIF1α, hypoxia inducible factor 1 subunit alpha; GSK3, glycogen synthase kinase 
3; BMP, bone morphogenetic protein; ERK, extracellular signal-regulated kinases; RTCA, RNA 3’-
terminal phosphate cyclase A; RTCB, RNA 3’-terminal phosphate cyclase B; MAG, myelin associated 
glycoprotein; CSPGa, chondroitin sulfate proteoglycan a; PARP1, poly (ADP-ribose) polymerase; 
mTOR, mammalian target of rapamycin complex; KAT2b, lysine acetyltransferase 2B; TET3, Tet 
methylcytosine dioxygenase. 
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1.4 Schwann cells  
1.4.1 Schwann cell development 
Schwann cells (SCs) are the glial cells ensheathing the peripheral nervous system. They 
supply the myelin that isolates axons from the outside environment, enhances the action 
potential conduction, and maintains the nerve fasciculation.  
Schwann cells are derived from neural crest cells and are sorted into mature myelinating 
and non-myelinating types in development. The development of Schwann cells consists of 
several stages, such as neural crest cell, Schwann cell precursors, immature Schwann cells, 
pro-myelinating Schwann cells and non-myelination Schwann cells or mature myelinating 
Schwann cells. Several signal pathways are involved in induction of the initial neural crest 
cells. For instance, activation of BMP (Bone morphogenetic) and FGF (fibroblast growth 
factor) combining with the Wnt pathway is essential for neural crest induction. After the 
neural crest cells successfully become the precursors, they are migrating and developing 
with the growing axons which supply survival signals. In addition, the NRG1 (Neuregulin 
1) and Erbb2/3 (Erb-b2 receptor tyrosine kinase 2/3) signaling pathways play pivotal roles 
in the successful development of Schwann cell precursors (Raphael and Talbot, 2011). In 
the next stage, the Notch signaling helps the Schwann cell precursors to develop into 
immature Schwann cells which lose the migratory capacity. When migration finishes, the 
immature Schwann cells start a process of radial sorting, in which the caliber of the axons 
determines whether the axons are myelinated or not. The large diameter axons are 
associated with the pro-myelinating Schwann cells and are wrapped by the compact myelin 
sheath. Specifically, the immature Schwann cells remodel their cytoskeleton and extend 
filipodia and lamellipodia, which facilitates pro-myelinating Schwann cells to wrap the 
axon for further myelination. Simultaneously, the non-myelinating Schwann cells form the 
Remak bundles with small diameter axons (Feltri et al., 2016; Salzer, 2015). Furthermore, 
several extracellular matrix adaptors with their receptors, such as laminin, collagen XV, 
integrins α6β1, dystroglycan and Rho family kinases, activate their downstream 
intracellular pathways to control the process of radial sorting (Monk et al., 2015). Besides 
the above factors, the following transcription factors, Sox10, Brn2, Oct6 and Krox20, are 
involved in the Schwann cells development and myelination (Jessen and Mirsky, 2005; 
INTRODUCTION 
15 
Nave and Salzer, 2006; Pereira et al., 2012). Recently, more receptors have been reported 
in myelination, such as G protein coupled receptors 44 (GPR44), GPR126, P2X7 and the 
gamma aminobutyric type B receptor (Faroni et al., 2014; Procacci et al., 2013) (Figure 
1.4 A). 
1.4.2 Schwann cells in neuron injury 
During the peripheral nerve injury, Schwann cells undergo different stages, including 
dedifferentiation, demyelination, activation and remyelination. That means the state of the 
promyelinating Schwann cells is dynamic in response to nerve injury.  
A significant phenomenon of Schwann cells after nerve injury is that the Schwann cells 
bridge the gap for guiding the regenerating axons across the injury area.  On both sides of 
the injury site, filopodia-like structures of Schwann cells which obtain a bipolar elongated 
morphology migrate and contact each other. This reflects the plasticity of the Schwann 
cells providing essential cues and structures for axon regeneration (Glenn and Talbot, 2013; 
Ide, 1996). The migratory behavior of the filopodia-like structure is controlled by ephrin B 
which is secreted by fibroblasts, EphB2, Sox2 and N-cadherin which are expressed by the 
Schwann cells. The EphB2 is activated by ephrin B and triggers the N-cadherin 
redistribution to the junction of Schwann cells by Sox2 signal pathway. This induces the 
repulsive behavior and causes the formation of the migratory structure for bridging the gap 
(Clements et al., 2017; Parrinello et al., 2010). In the proximal part of the distal stump of 
the injury nerves, the Schwann cells which lose the contact with axons (degenerate 
automatically), lose the capacity of myelin production and proliferate to present the 
daughter Schwann cells to the injury site. In this case, some of the Schwann cells migrate 
into the injury gap to facilitate the axons to get over this region. However, the far-side 
Schwann cells in the distal stump dedifferentiate and lose their original cellular 
morphology. This pro-regenerative feature of the repairing Schwann cells are from the 
myelinating Schwann cells which undergo several components upregulating p75NTR 
(Nerve growth factor receptor), NCAM (Neural cell adhesion molecule), GFAP (Glial 
fibrillary acidic protein) and mTOR1 (Mammalian target of rapamycin complex1)) and 
decreasing the expression of MBP (Myelin binding protein), MAG (Myelin associated 
glycoprotein) and P0 (Myelin protein zero) (Boerboom et al., 2017; Norrmén et al., 2018). 
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The activating of c-Jun transcription factor and modification of the DNA are also involved 
in this conversion. When the new axons regrow to their targets, the repairing Schwann cells 
are activated and gain the capacity to myelinate the new axons again. Many factors are 
participating in this process. For instance, IL-1α (Interleukin 1 alpha), IL-1β (Interleukin 1 
beta), LIF (Leukemia inhibitory factor) and MCP1 (Monocyte chemoattractant protein1) 
which recruit the neutrophils and macrophages to the injury axons are upregulated in the 
repairing Schwann cells (Martini et al., 2008; Rotshenker, 2011), accelerate the clearance 
of the fragment axons. Moreover, Schwann cells activate the breakdown process of myelin, 
which is beneficial for new axons regrowth. It should be mentioned that several factors in 
the extracellular space of Schwann cells or axons contribute to the nerve repair. For 
example, the neurotrophic factors, GDNF (Glial-derived neurotrophic factor), BDNF 
(Brain-derived neurotrophic factor), VEGF (Vascular endothelial growth factor), and 
artemin, promote the axons regrowth and elongation (Brushart et al., 2013; Eggers et al., 
2010; Fontana et al., 2012) (Figure 1.4 B). 
 
Figure 1.4 The development of Schwann cells (SCs) and Schwann cells response to injury.  A) 
Illustration shows the development of Schwann cells from neural crest cells to Schwann cell precusors, 
radial sorting immature Schwann cells, promyelinating and myelinating Schwann cells; B) shows the 
SCs response to injury. The myelinating SCs are converted reversibly into repair SCs under the control 
of the indicated factors. These factors are separated into Pons for promoting the process and Cons for 
inhibiting the process of transfer between myelinating and repair SCs. GPR126, G-protein coupled 
receptor 126; NRG1, neuregulin 1; ErbB, Erb-B2 receptor tyrosine kinase; TGF, Transforming growth 
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factor; HDAC2, histone deacetylase 2; cAMP, cyclic adenosine monophosphate; Oct6, octamer-binding 
protein 6; Sox2, SRY (sex determining region Y)-box 2; Pax3, paired box 3; Id2, inhibitor of DNA 
binding 2; ZEB2, zinc finger E-box binding homeobox 2. 
1.4.3 Communication between Schwann cells and axons 
Neuregulin is important for development of the normal neuronal connectivity. Its EGF-like 
domain is for interaction with ErbB receptors which are expressed on the Schwann cells. 
The Nrg1-Erbb signaling is involved in myelination, synaptic transmission and survival of 
neurons and glial cells. Nrg1-TypeIII, expressed by Schwann cells, induces Schwann cells 
dedifferentiation and Remak formation. The activation of Nrg1 is by cleavage of the 
extracellular part. Nrg1 is positively regulated by β-secretase (BACE1) which cleaves Nrg1 
and releases the N-terminal fragment (Nrg1-ntf). Moreover, ADAM17 (A disintegrin and 
metalloproteinase 17) has been reported to be involved in BACE1 (β-secretase1) cleavage 
of Nrg1. The Nrg1-ntf binds erbb4 and increases ERK (Extracellular signal-regulated 
kinases) and AKT (Protein kinase B) phosphorylation, which plays a role in cell survival, 
synaptic development and remyelination. The C-terminal fragment of Nrg1 participates in 
enhancing the synaptic plasticity (Krivosheya et al., 2008; Luo and Park, 2012; Zhang et 
al., 2017).  
Neurogenic locus notch homolog protein (Notch) controls Schwann cell proliferation and 
Schwann cell-axon interaction in development. It promotes Schwann cell maturation from 
Schwann cell precursors and maintains myelin as a negative regulator. Downregulation of 
Notch leads to premature myelination, while the overactivation of Notch delays myelin 
formation (Boerboom et al., 2017; Woodhoo et al., 2009). 
Neurotrophin is involved in Schwann cell-axon interaction in both directions: from axons 
to Schwann cells and vice versa. It has two members, BDNF and NT3. BDNF can bind to 
the p75 from Schwann cells, promoting myelination in the early stages (Brushart et al., 
2013; Piirsoo et al., 2010). However, it also binds to TrkB, which inhibits myelination at 
later stages (Zhang et al., 2016). NT3 promotes SC migration, but it inhibits myelination 
in in vitro experiments. Deficient NT3 mice have shown hypomyelination axons in 
development (Sahenk et al., 2008). 
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Nectin-like proteins are expressed in the Schwann Cell-axon interactions, known as cell 
adhesion molecules (CADM). Indeed, SC-derived Necl-1/Cadm3 and axonal Necl-
4/Cadm4 regulate PNS myelination in vitro (Maurel et al., 2007; Monk et al., 2015). 
GPR126 is required for myelination of the peripheral neurons. Schwann cells secreted 
collagen IV is an ECM (Extracellular matrix) protein that modulates and activates GPR126. 
The Gα subunit of GPR126 increases cAMP (Cyclic adenosine monophosphate) level and 
activates PKA for initiating myelination (Mogha et al., 2013; Paavola et al., 2014). 
Laminin, another ECM protein, is a new ligand for GPR126 that controls the early and late 
stages of Schwann cell development by modulating the receptor signaling via a tethered 
agonist (Petersen et al., 2015). GPCR44 promotes peripheral nervous system myelination 
by activating the Nfact4 (Nuclear Factor Of Activated T Cells 4) which is in the 
downstream of NRG1 signaling (Trimarco et al., 2014). 
1.5 Sarm1 
Sarm1 is conserved from Caenorhabditis elegans, Drosophila and mammals. It contains 
the HEAT/Armadillo domain, unique sterile alpha (SAM) motifs, and a Toll-interleukin-1 
receptor (TIR) domain. Sarm1 is highly expressed in neurons, astrocytes and the liver, 
which localizes to the cytoplasm and the mitochondria (Mink et al., 2001; Murata et al., 
2013; Pan and An, 2018). In human neuronal cell line SH-SY5Y, the protein level of sarm1 
is enhanced after mitochondrial depolarization (Murata et al., 2013). In human PBMC (a 
peripheral blood mononuclear cell), LPS (lipopolysaccharide) treatment dramatically 
increased sarm1 protein, but Sarm1 mRNA was suppressed coincidentally, suggesting that 
Sarm1 mRNA and protein are regulated independently (Carty et al., 2006). In addition, the 
angiotensin II receptor antagonist and kainic acid can enhance the expression of Sarm1 in 
brain or retinal ganglion cells (Balaji et al., 2015; Massoll et al., 2013). 
1.5.1 Sarm1 in immunology  
The C.elegans ortholog of Sarm1, Tir-1, is involved in worm development and innate 
immunity. The expression of two peptides, NLP (neuropeptide-like protein)-29 and NLP-
31, is regulated by Tir-1 when C. elegans is infected by fungi or bacteria (Couillault et al., 
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2004). In mammals, Sarm1 negatively regulates TRIF (TIR-domain-containing adapter-
inducing interferon-β)-dependent Toll-like receptor signaling. Knockdown of SARM by 
RNAi enhances TRIF-dependent chemokine and cytokine induction (Carty et al., 2006). 
Additionally, Sarm1 regulates TLR signaling when Burkholderia pseudomallei infect 
murine macrophages. Then, the expression of Sarm1 is increased in macrophages, which 
inhibits TRIF and reduces IFN-β (Interferon beta) production, indicating that Sarm1 is a 
negative regulator in TLR signaling (Baral and Utaisincharoen, 2013; Pudla et al., 2011). 
However, some reports show positive roles of Sarm1 in TLR signaling. For instance, in 
neurons, Sarm1, not the MyD88 (myeloid differentiation primary response 88), is reported 
to mediate TLR7 and TLR9-induced apoptosis (Mukherjee et al., 2015). In the non-alcohol 
fatty acid liver disease (NAFALD), Sarm1 deletion reduces inflammation via reduction of 
TLR2/7/9 responses. Moreover, Sarm1 induces the expression of TLR and 
proinflammatory cytokine in response to HFD (high fat diet) in the liver and hypothalamus 
(Pan and An, 2018). Recently, it has been reported that activation of Sarm1 dependent JNK 
pathway is required for neurons responding to traumatic injury by chemokines (Ccl2, Ccl7, 
Ccl12 and Csf1) production. Deletion of genes in the Sarm1-JNK-C-Jun pathway 
effectively blocks immune cells from being recruited into the injury of neural tissues 
(Wang et al., 2018).  
1.5.2 Sarm1 in neurobiology  
The role of Sarm1 in neurons was first uncovered in C. elegans. Tir-1 activates NSY-
1/ASK1 kinases to regulate diversifies odorant receptors expression (Chuang and 
Bargmann, 2005). In mammals, MyD88-5/Sarm1 is highly expressed in the brain, which 
interacts with and recruits JNK3 to mitochondria. The hippocampal neurons from Sarm1-
null mice resist cell death after oxygen and glucose deprivation (Kim et al., 2007). In La 
Crosse virus (LACV) inducted neuronal cell death, the expression of SARM1 is 
upregulated by MAVS (mitochondrial antiviral signaling protein) which induces the cell 
death upon mitochondrial damage or oxidative stress response (Mukherjee et al., 2013). In 
addition, Sarm1 plays an important role in neuronal morphology. Specifically, Sarm1 binds 
to syndecan-2 which is a synaptic heparin sulfate proteoglycan in mouse brain, where 
Sarm1 transfers signals from syndecan-2 to ASK-MEK4/7-JNK signaling pathway to 
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regulate neuron dendritic arborization. However, the expression of Sarm1 precedes the 
expression of syndecan-2 in the brain, indicating that Sarm1 also has a syndecan-2 
independent way to control axonal outgrowth and neuronal polarity formation (Chen et al., 
2011). In the sensory neurons, Sarm1 functions downstream of ROS (reactive oxygen 
species) generation inducing cell death. Deletion of Sarm1 blocks cell death but not ATP 
deletion, ROS accumulation under CCCP treatment (Summers et al., 2014). 
1.5.3 Sarm1 in neuron degeneration  
In flies and mice, deletion of dSarm1 or Sarm1 prevents the Wallerian degeneration in 
axotomy (Osterloh et al., 2012). The SAM domain of Sarm1, which mediates the 
multimerization of proteins, is not essential for triggering axon degeneration. However, the 
TIR (Toll‐interleukin receptor) domain is important for activating downstream signaling 
pathway to execute axon degeneration and non-apoptotic neuronal death. In addition, the 
N-terminal mitochondrial targeting sequence is not required for the function of Sarm1, but 
ablation of the N-terminal armadillo domain actives axonal degeneration and cell death 
without injury, suggesting that the armadillo domain is a negative regulator of Sarm1 
(Gerdts et al., 2013). The evolutionary study suppose that Sarm1 likely develops from 
bacterial TIR proteins but not from animal TIR protein in the phylogenetic trees. It is 
possible that the gene transfers between the bacteria and the ancestor of ecdysozoa and 
deuterostomes (Malapati et al., 2017; Zhang et al., 2011). Moreover, bacterial TIR proteins, 
TirS, possess the NADase activity and effect the macrophage response to infection (Patot 
et al., 2017). The Sarm1-TIR has the NADase activity that is necessary for pathological 
axon degeneration, which cleaves NAD+ into Nam, ADP-ribose (ADPR), cyclin ADPR, 
and nicotinamide (Essuman et al., 2017).  
TIR domain dimerization can promote axon degeneration directly both in vitro and in vivo, 
indicating that the dimerization of TIR domains is required for axonal degeneration. 
Dimerization of TIR triggers the consumption of NAD and ATP in a short period, and the 
decrease of NAD is much faster than depletion of ATP. However, in Sarm1 deficient nerve, 
the decline of NAD and ATP is retarded, which maintains the transected axons stable. In 
addition, increasing NAD synthesis can partly block the axonal degeneration which is 
induced by TIR dimerization (Di Stefano et al., 2015; Gerdts et al., 2015). Enhancing the 
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NAD consumption can execute the axonal degeneration in Sarm1 null axons, indicating 
that NAD loss is required for axon degeneration but not the outcomes. Additionally, poly 
(ADP-ribose) polymerase and CD38 deletion do not block the Sarm1 induced NAD loss, 
axon fragmentation, and cell death (Gerdts et al., 2015). However, in another study, 
deletion of Sarm1 does not prevent the decline of NAD and NMN in the transected neurite 
(Gilley et al., 2015).  
Sarm1 is required for NMN induced Wallerian degeneration, because NMN requires Sarm1 
to stimulate Ca2+ influx. Inhibition of NMN synthesis and Sarm1 deficiency block Ca2+ 
influx and remain axonal integrity (Loreto et al., 2015). Genetic ablation of NMNAT2 is 
embryonic lethal with dramatic defects of axon extension in the embryos in mouse. The 
double mutant animals, NMNAT2-/-Sarm1-/-, are able to develop into adult. Sarm1 
knockout rescues the defects induced by NMNAT2 deficiency. NMNAT2 is the upstream 
component of Sarm1 in axon degeneration by inhibiting the activity of Sarm1 (Gilley et 
al., 2015).  More studies show that Sarm1 activates mitogen-activated protein kinase 
(MAPK) signaling pathway in the axon, including the MAPK kinase kinase (MAPKKK), 
MAPK kinase (MAPKK), and MAPK members, c-Jun N-terminal kinase 
(JNK1/JNK2/JNK3). In addition, axotomy induces Sarm1 dependent MKK4 
phosphorylation in mammalian optic nerves. This phosphorylation event can be diminished 
by overexpression of NMNAT1 (Yang et al., 2015a). The injury activating Sarm1-MAPK 
pathway promotes axonal degeneration, but it can be antagonized by AKT which inhibits 
the activation of JNKs (Yang et al., 2015a). This suggests that the AKT is an inhibitor of 
axon degeneration after axotomy. The kinase AKT phosphorylates MKK4 directly at Ser78 
to preserve the axons after injury. The protein level of AKT is regulated by ZNRF1 
mediated proteasomal degradation following axon injury (Wakatsuki et al., 2011), which 
accelerate the axon degeneration by removing the inhibitor of MAPK signaling (Gerdts et 
al., 2016; Yang et al., 2015a). Sarm1 interacts with JNK3 which participates in 
mitochondrial apoptosis pathways (Kuan et al., 2003), and Sarm1 recruits JNKs to 
mitochondria to regulate cell apoptosis under glucose deprivation and hypoxia (Kim et al., 
2007). Recent study shows that phosphorylated SARM1 at serine 548 by JNK under 
oxidative stress conditions, results in NAD+ cleavage activity enhancement and 
mitochondrial respiration inhibition. In Parkinson’s disease (PD) patient, the 
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phosphorylation of Sarm1 is increased and the neurons are more sensitive to oxidative 
stress, comparing to the neuronal cells from a healthy person (Murata et al., 2018). The 
Sarm1-MAPK pathway induces calpain activation and axon morphological degeneration 
by triggering energy deficit in the injured axons, which precedes proteolysis of axonal 
cytoskeletal proteins degradation and axon degeneration. Either depletion of Sarm1, 
MKK4/MKK7, or JNKs, maintains the ATP levels in the injured axons (Yang et al., 2015a) 
(Figure 1.5).  
 
Figure 1.5 The network of Sarm1 in axon degeneration. This network shows the molecules and 
signalling pathways in Sarm1 induced axon degeneration. The central axis is the NAD+, ATP, Ca2+, and 
cytoskeleton breakdown for axon degeneration. Activation of Sarm1 (TIR dimerization) and 
phosphorylation of  Sarm1 increased the consumption of NAD+ which triggers axon degeneration. 
Axotomy can active Sarm1 directly or through down regulation of NMNAT2. The oxidative stress 
promotes JNK to phosphorate Sarm1 in axon degeneration. NMNAT, nicotinamide mononucleotide 
adenylyltransferase; NMN, β-nicotinamide mononucleotide; NAD, nicotinamide adenine dinucleotide; 
MAPK, mitogen-activated protein kinase; AKT, Protein kinase B; JNK, C-Jun N-terminal kinase; ATP, 
adenosine triphosphate.   
1.5.4 Sarm1 in neuron pathology  
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Lack of Sarm1 improves traumatic brain injury (TBI) associated phenotypes after injury. 
Sarm1 knockout mice have less β-amyloid precursor protein aggregation in the axons of 
the corpus callosum, comparing to the wild type mice in TBI. In addition, the behavioral 
deficits in the wild type mice after TBI is attenuated in the Sarm1 KO mice (Henninger et 
al., 2016). Peripheral neuropathy is the major side effect in clinical trials, especially in 
chemotherapy. Sarm1 deletion preserves nerve fibers following vincristine treatment in 
mice, indicating that genetic ablation of Sarm1 inhibits the vincristine-induced peripheral 
neuropathy in mice (Geisler et al., 2016). Moreover, Sarm1 participates in the development 
of Amyothrophic lateral sclerosis (ALS). In the C.elegans ALS model, tir-1 deletion 
suppresses the motor neuron degeneration via the regulation from UNC-13 and UNC-31. 
The components in this pathway may be the new targets sites for ALS therapy (Carty and 
Bowie, 2019; Vérièpe et al., 2015).  
1.6 Chemotherapy and neuropathy  
Chemotherapy–induced peripheral neuropathy (CIPN) is the main adverse effect 
associated with chemotherapeutic agents in patients (Starobova and Vetter, 2017). The 
most popular reagents include the vinca alkaloids (vincristine), taxanes (paclitaxel, 
docetaxel), platinum-based antineoplastics (oxaliplatin, cisplatin), immunomodulatory 
drug (thalidomide), and the proteasome (bortezomib). These drugs increase the survival 
rates of patients, but the side-effect makes numbers of survivors suffering from the pain of 
neuropathy (Seretny et al., 2014) (Tabel 1.2). The damages to peripheral sensory and motor 
neurons are dose dependent and progressive (Kautio et al., 2011). Additionally, the 
conditions of  patients, such as pre-existing nerve damage or diabetes, also relate to the 
development of CIPN (Starobova and Vetter, 2017). CIPN shows the deficits in sensory 
nerves, motor nerves, and autonomic function with the agent specific manner (Park et al., 
2013b). Specifically, sensory symptoms develop in the sensory neurites, including the 
sense to touch, temperature, vibration and pain. The severe cases present the loss of sensory 
perception (Bernhardson et al., 2007; Postma et al., 1993; Sahenk et al., 1994; Strumberg 
et al., 2002). Motor symptoms display impaired fine movements and balance disturbances. 
It can progress to paralysis and loss of motor functions which are more severe than the 
deficits in sensory nerves (Mols et al., 2016). About the autonomic symptoms, which occur 
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in the compound specific manner and less frequent. The symptoms involve constipation, 
orthostatic and urinary function (Mols et al., 2016). Strikingly, CIPN can cause irreversible 
sensory neuron deficit in severe cases (Starobova and Vetter, 2017). Due to inadequate 
efficacy or adverse effects of the agents, it is urgent to find novel and systematic approaches 
to quickly evaluate the drugs and their side effect. Zebrafish could be a powerful model 
system to promote novel drugs discovery and evaluate the drug toxicity and efficacy 
(Holloway et al., 2016). 
1.6.1 Mechanism of CIPN 
The mechanism of chemotherapeutic agents resulting in CIPN has been studied for many 
years. The potent effects of these agents on cell proliferation and cell death are relatively 
well understood. For instance, disrupting axonal transport, axonal degeneration, and 
mitochondrial function have been reported to contribute to CIPN. But the additional side-
effects are not clear (Starobova and Vetter, 2017) (Table 1.2).  
 
Table 1.2 Chemotherapeutic drugs implicated in CIPN. This table shows a brief description of the 
chemotherapeutic drugs and the mechanisms of the drugs for therapy, and the side-effect for the patients.  
The platinum agents (Oxaliplatin and Cisplatin), side-effect in nephrotoxicity and 
neurotoxicity, lead to cell cycle arrest and apoptosis by forming platinum-DNA adducts 
(Johnstone et al., 2014; Suchánková et al., 2012). Besides the DNA level damage, they also 
affect transmembrane receptors and ion channels (Cavaletti et al., 2001; Grolleau et al., 
2001; McDonald and Windebank, 2002). For instance, oxaliplatin which causes sensory 
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neuropathy, affects axonal excitability by ion channel dysfunction and dysregulation of 
calcium homeostasis, and alters the function of potential channels of transient receptors. 
Moreover, oxaliplatin induces neuronal and glial cell dysfunction and death by activating 
the caspases, mitogen-activated protein kinases (MAPK) and protein kinase C (PKC) 
(Carozzi et al., 2015; Cersosimo, 2005). However, cisplatin reduces loss of large 
myelinated fibers and sensory nerve action potentials (Krarup-Hansen et al., 2007). In 
addition, it interferes in cell division and transcription of messenger ribonucleic acid 
(mRNA) and affects the calcium signaling pathway related kinase proteins (MAPK, JNK, 
PKC and AKT) (Dasari and Tchounwou, 2014).  
Paclitaxel, one agent of taxanes, targets the microtubules during the cell cycle and causes 
sensory neuropathy with axonal degeneration (Jordan and Wilson, 2004). The study in 
zebrafish showed that paclitaxel accumulates in the basal keratinocytes and enhances the 
expression of epidermal matrix-metalloproteinase-13. Moreover, paclitaxel promotes 
sensory axon degeneration and weakens the touch response in the distal caudal fin (Lisse 
et al., 2016).  
Vincristine from vinca alkaloids, has the high affinity to α-tubulin, leading to mitotic arrest 
and cell death in sensory and motor neurons (Gan et al., 2010). In the rat model, vincristine 
decreases the expression of endomorphin-2, which attenuates allodynia and central 
sensitization in the spinal cord (Yang et al., 2015b). Vincristine disrupts calcium 
homeostasis and membrane remodeling of peripheral neurons, causes loss of large 
myelinated fibers, and activates immune system and subsequent neuroinflammation in the 
CIPN mice (Boehmerle et al., 2014; Carozzi et al., 2015).  
Thalidomide causes peripheral neuropathy in sensory or sensorimotor secondary to 
microvascular changes as its anti-angiogenic properties. It decreases the expression of 
tumor necrosis factor alpha (TNF-α), which protects neurons avoiding death in an 
inhibitory manner (Addington and Freimer, 2016; Coutsouvelis and Corallo, 2004; 
Dimopoulos et al., 2007).  
Proteasome inhibitor, bortezomib, inhibits the 26s ribosome subunit, preventing protein 
degradation, and affects the polymerization of α-tubulin, leading to cell cycle arrest and 
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apoptosis (Curran and McKeage, 2009; Poruchynsky et al., 2008). In the Wistar rat study, 
the bortezomib induces satellite cell intracytoplasmic vacuolization by damaging the 
mitochondria and endoplasmic reticulum. It also causes moderate pathological changes in 
Schwann cells, myelin, and axonal degeneration in DRG, but the morphology of spinal 
cord is normal (Cavaletti et al., 2007).  
1.6.2 CIPN and Axon transport, axonal degeneration 
Platinum, vinca alkaloids and bortezomib inhibit the processes of tubulin polymerization 
and depolymerization, which affects the microtubule dynamics. Microtubule dynamics is 
important for both of the anterograde and the retrograde transport which is relying on axon. 
Disrupting microtubule dynamics induces dysfunction of the axonal cytoskeleton, which 
contributes to the development of neuropathy. In addition, axon degeneration, either 
directly or indirectly caused by the chemotherapeutic agents, is a significant phenotype in 
neuropathy. The axonal response to injury linked to CIPN has been reported in several 
studies. Axonal degeneration with myelinated fibers was revealed with electron 
microscopy in peripheral nerves in patients treated with cisplatin. In addition, vincristine, 
paclitaxel, and oxaliplatin were also reported to induce sensory axon degeneration and loss 
of nerve fibers (Argyriou et al., 2008; Boehmerle et al., 2014; Boyette-Davis and 
Dougherty, 2011; Sahenk et al., 1994).  
Blocking axon degeneration could be a way to attenuate the neuropathy. The initial 
experiments show that the cultured dorsal root ganglion neurons from Wlds mouse have 
relative resistance to vincristine induced neuropathy (Wang et al., 2001). Recently, Sarm1 
deficient mice have been shown to be resistant to vincristine or paclitaxel induced axon 
degeneration (Geisler et al., 2016; Turkiew et al., 2017). Sarm1 has the NADase activity 
which depletes NAD+ in axon degeneration. In the vincristine induced neuropathy 
experiments, Sarm1 intrinsic NADase activity is required for axon degeneration. Inhibiting 
the NADase activity, vincristine induced axon degeneration can be significantly blocked 
(Essuman et al., 2017). More evidences show that constitutive expression NMNAT1 or 
NMN deaminase is involved in protecting animals against by vincristine induced peripheral 
neuropathy (Di Stefano et al., 2017; Sasaki et al., 2009). Both of NMNAT1 and MNM play 
roles in the Sarm1 mediated axon degeneration. Therefore, inhibition of the pro-
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degeneration cellular pathway for axon degeneration, such as Sarm1, or enhancing the anti-
degeneration molecules, such as NMNAT1 or NMN deaminase, could be a useful strategy 
to attenuate the side adverse of chemotherapeutic agents (Fukuda et al., 2017).  
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2. Aims  
Upon peripheral nerve injury, Schwann cells dedifferentiate to promote the clearance of 
axon fragments ahead of axonal re-growth from the proximal stump which remains 
associated to the neuronal perikaryon (Jessen et al., 2015). Expeditious axonal regeneration 
is important because sustained Schwann cell denervation leads to protracted loss of glial 
terminal phenotype and eventual death of neuron. In turn, glial cell loss impairs 
regenerating nerve myelination and circuit repair, transforming acute neuropathies into 
irreversible chronic neurological dysfunction. Therefore, inhibiting or delaying axon 
destruction has been hypothesized as an effective strategy to counter heightened Schwann 
cell vulnerability to additional stressors that include metabolic imbalance and drugs 
(Jortner, 2000; Morell and Toews, 1996). This idea has sparked intense academic and 
commercial efforts to identify specific molecular inhibitors of axon degeneration for 
clinical applications (Koeppen, 2004; Simon and Watkins, 2018). Sarm1 has been reported 
in regulating axon degeneration after injury. In Drosophila and mouse, loss of dSarm1 or 
Sarm1 prevents the Wallerian degeneration of transected nerves (Osterloh et al., 2012). 
Sarm1-deficient mouse has been reported to attenuate axonal injury and to improve 
functional outcome after traumatic brain injury. Thus, Sarm1 could be a possible target for 
clinical application. However, in case of the Sarm1 inhibition which causing axonal 
degeneration blocking, the potentially deleterious effect and the recovery ability of the 
injury nerve remain unknown. In addition, the influence of Sarm1 deficiency on Schwann 
cells, on the macrophages response to axon degeneration, and on behavioral performance 
is still unclear.  
Zebrafish is a small vertebrate whose nervous system is anatomically simpler but 
structurally and functionally similar to that of mammals (Friedrich et al., 2013). Crucially, 
zebrafish larva is ideal to study axonal degeneration and regeneration, and Schwann-cell 
biology in the natural context of the behaving animal (Bin and Lyons, 2016; Rosenberg et 
al., 2014; Xiao et al., 2015a). Moreover, its nervous system is as functionally sophisticated 
as that of adult zebrafish. Yet, it is anatomically simpler, rendering it ideal for high-
resolution observation and controllable experimental manipulations.  
AIMS 
29 
The aim of my study was to answer a number of seminal questions about the roles of Sarm1 
in sensory neurons and glial cells, axon degeneration and regeneration; the effect of Sarm1 
deficiency on the development and behavioral performance of zebrafish; the possibility of 
clinical applications by inhibiting Sarm1. The specific aims of my thesis are following: 
1) To generate the loss of Sarm1 zebrafish. There is no report about Sarm1-deficient 
zebrafish until now. The Sarm1-knockout fish is the fundamental tool to exploit the 
role of Sarm1 in zebrafish. 
2) To investigate the role of Sarm1 in axon degeneration and regeneration in zebrafish. 
Taking the advantage of zebrafish, it is possible to study the process of axonal 
degeneration and regeneration by taking long-time live imaging with high-
resolution microscopy. 
3) To reveal the role of Sarm1 in the development of Schwann cells and the role of 
Schwann cells in axon degeneration and regeneration. With the Sarm1-deficient 
zebrafish, I can furtherly study the dynamics of Schwann cells in axon degeneration 
and regeneration and the role of Sarm1 in Schwann cells. 
4) To assess the role of Sarm1 in macrophage response to injury and fragmented axons. 
With the transparent zebrafish larva, it is possibly to assess the behavior of the 
macrophages in vivo. 
5) To evaluate the possibility of targeting on Sarm1 as the clinical application to 
reduce chronic consequence of nerve injury systemically. Here, I combine 
microsurgery, multicolor high-resolution intravital microscopy, electrophysiology, 
pharmacology and behavioral tests to provide novel insights of Sarm1 into the 
cellular basis of axon degradation, nerve repair, and the possibility of Sarm1 
inhibition for clinical application. 
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3. Materials and Methods 
3.1 Zebrafish strains and husbandry 
a. The zebrafish lines for my experiments were the following strains: 
AB (Faucherre et al., 2009) 
Casper (Faucherre et al., 2009) 
Tg[UAS:EGFP] (Faucherre et al., 2009) 
Tg[HGn39D]                                (Faucherre et al., 2009) 
Tg[SILL:mCherry] (Faucherre et al., 2009) 
Tg[Brn3c] (Faucherre et al., 2009) 
Tg[gSAGFF202A] (Xiao et al., 2015a) 
Tg[UAS:GCaMP7a] (Muto et al., 2013), 
Tg[MBP:tgRFP] (Auer et al., 2018), 
Erbb2 mutants (Lyons et al., 2005; Xiao et al., 2015a) 
Tg[Sarm1-/-] (in this thesis) 
Tg[mfap4:EGFP-CAAX] (in this thesis) 
Tg[SILL:ratTRPV1-tgRFP] (in this thesis) 
b. The zebrafish (Danio rerio) were maintained in a centralized facility in accordance 
to guidelines by the Ethical Committee of Animal Experimentation of the 
Helmholtz Zentrum München, the German Animal Welfare act Tierschutzgesetz 
§11, Abs. 1, Nr. 1, Haltungserlaubnis, to European Union animal welfare, and to 
protocols number Gz.:55.2-1-54-2532-202-2014 and Gz.:55.2-2532.Vet_02-17-
187 from the “Regierung von Oberbayern”, Germany.   
The facility keeps 14/10 h light/dark cycle at 28.5 °C. The embryos for experiments 
were kept with E3 or 30% Danieau’s solution in incubator at 28.5°C. All the 
experiments were performed strickly in accordance with the protocols.  
3.2 List of chemicals and reagents 
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Paraformaldehyde (PFA) Sigma-Aldrich, P6148 
Tricaine (MS-2222) PharmQ, UK 
Sodium chloride (NaCl) Merck, 1.06404.5000 
Potassium chloride (KCl) Sigma-Aldrich, P9541-500G 
Calcium chloride dihydrate (CaCl2·2H2O) Sigma-Aldrich, C3306-250G 
Magnesium sulfate (MgSO4) Sigma-Aldrich, M5921 500G 
Trizma (TRIS base) Sigma-Aldrich, G8898 
Sodium dodecyl sulfate (SDS) Sigma-Aldrich, L3771 
Glycine Sigma-Aldrich, T1503-1KG 
HCl Sigma-Aldrich, H1758-500ML 
Ammonium persulphate (AP) Sigma-Aldrich, 215589 
Tetramethylethylenediamine (TEMED) Sigma-Aldrich, T7024 
Kanamycin sulfate Sigma-Aldrich, 60615 
Ampicillin Sigma-Aldrich, 10835242001 
capsaicin Sigma-Aldrich, M2028 
10-Hydroxycamptothecin (10-HCT) Sigma-Aldrich, H3148 
Blotto, non-fat dry milk  Santa Cruz, sc-2324 
Paclitaxel Cayman CHEMICAL, 10461 
Docetaxel Cayman CHEMICAL, 11637 
Oxaliplatin AdipoGen, AG-CR1-3592-M005 
Cisplatin Cayman CHEMICAL, 13119 
Vincristine Santa Cruz, sc-201434 
QIAquick Gel Extraction kit Cat.no.28706 
DH5ɑ Competent Cells Thermo Scientific™, 18263012 
TOP10 competent cells Invitrogen™, C404010 
DraI Thermo Scientific™, FD0224) 
BsaI Thermo Scientific™, FD0294 
PmeI Thermo Scientific™, ER1341 
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NotI Thermo Scientific™, FD0595 
REDExtrac-N-AmpTM Tissue PCR Kit Sigma-Aldrich 
Extraction Solution Sigma-Aldrich, E7526 
Tissue Preparation Solution Sigma-Aldrich, T0373 
Neutralization Solution B Sigma-Aldrich, N3910 
DreamTaq Thermo Scientific™, EP0702 
T4 ligase NEB, M0202 
poly (A) tailing kit Ambion™, AM1350 
MEGA shortscript T7 Ambion™, AM1334 
mMESSAGE mMACHINE T7 kit Ambion™, AM1344 
mMESSAGE mMACHINE SP6 kit Ambion™, AM1340 
BP Clonase™ Enzyme Mix Invitrogen™, 11789-013 
LR Clonase™ Enzyme Mix Invitrogen™, 11791-019 
RIPA lysis buffer Thermo Scientific™, 89900 
BCA Protein Assay Kit Pierce™, 23227 
Protease inhibitor cocktail Roche, 04693159001 
30% Acrylamide/Bis solution, 29:1 BioRad, 1610156 
PVDF membrane Thermo Scientific™, LC2005 
Prestained Protein Ladder Thermo Scientific™, 26619 
Mouse anti-acetylated tubulin Sigma-Aldrich, T7251 
Rat anti-Claudin-k (Münzel et al., 2012) 
Mouse anti-6D2 (López-Schier and Hudspeth, 2005) 
Rabbit anti-Sarm1 ANASPEC, 55381 
Mouse anti-β-Tubulin Sigma-Aldrich, T5168 
Donkey anti-Mouse Alexa Fluor® 555 Abcam, ab150106 
Pierce™ ECL Western Blotting Substrate Thermo Scientific™, 32109 
UltraPure™ Low Melting Point Agarose Invitrogen™, 16520100) 
VectaMount® Permanent Mounting Medium VECTOR, Cat. NO: H-5000 
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Donkey anti-Rat IgG H&L (Alexa Fluor® 
647) pre-adsorbed 
Abcam, ab150155 
Peroxidase-Affini Pure Goat Anti-Mouse IgG 
(H+L) 
Jackson ImmunoResearch, 115035003 
Peroxidase-Affini Pure Goat Anti-Rabbit IgG 
(H+L) 
Jackson ImmunoResearch, 115035144 
3.3 List of plasmids and primers 
1    List of plasmids 
pMLM3613 Addgene, 42251 
pDR272 Addgene, 42250 
SILL:mCherry (Faucherre et al., 2009) 
SILL:Gal4 (Faucherre et al., 2009) 
pCS2+-Tp Transposase (Faucherre et al., 2009) 
mbp:EGFP-CAAX (Auer et al., 2018; Czopka and Lyons, 2013) 
UAS: ratTRPV1-tagRFP (Tim Czopk lab) 
pDONR221 (Faucherre et al., 2009) 
pDONRP2R-P3 (Faucherre et al., 2009) 
pDestTol2pA2 (Faucherre et al., 2009) 
p3E-mCherry (Faucherre et al., 2009) 
p3E-polyA (Faucherre et al., 2009) 
SILL:Sarm1-v2a-mCherry (in this thesis) 
SILL:Sarm1△TIR-v2a-mCherry (in this thesis) 
SILL:mito-mCherry (in this thesis) 
SILL:Kaede (in this thesis) 
Sill:Synapsin1-mCherry (in this thesis) 
mfap4:EGFP-CAAX (in this thesis) 
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SILL:mitoRGECO (in this thesis) 
SILL:erGCaMP3 (in this thesis) 
SILL:ratTRPV1-tagRFP (in this thesis) 
The plasmids were generated using Tol2 kit (Kwan et al., 2007). Mitochondria in 
lateralis neurons were marked by expressing the mitochondria targeting sequence 
from the Cytochrome-C oxidase subunit 8A fused to mCherry. The plasmids 
containing mito-RGECO and er-GCaMP3 (Esterberg et al., 2016) were gifts from 
David W. Raible (University of Washington). 
2    List of primers (sequence 5’-3’) 
sgRNA (sarm1) oligonucleotides:  
oligo1_TAGGGACTTGGAAGAGACCCGC  
oligo2_AAACGCGGGTCTCTTCCAAGTC 
Genotyping primers for Sarm1 mutants:  
Forward_GATTTGCCGTTATCTCTCCA  
Reverse_TCAAGCAGTTTGGCAGACTC 
pMiddle-Sarm1-v2a-mCherry: 
Forward_GGGGACAAGTTTGTACAAAAAAGCAGGCTCAGCCACCATGTT
TTTGTCCCTCGTCGT 
Reverse_GGGGACCACTTTGTACAAGAAAGCTGGGTACTACTTCTTTTGT
GGCTCTTTTT 
overlap of mCherry and the v2A sequence:  
Forward_TCATCTCAGAAGAGGATCTGGGAAGCGGAGCTACTAACTTCA
GCCTGCTGAAGCAGGCTGGAGACGTGGAGGAGAACCCTGGACCTATG
GTGAGCAAGGGCGAGGA 
Reverse_TCCTCGCCCTTGCTCACCATAGGTCCAGGGTTCTCCTCCACGT
CTCCAGCCTGCTTCAGCAGGCTGAAGTTAGTAGCTCCGCTTCCCAGAT
CCTCTTCTGAGATGA’ 
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pMiddle- Sarm1△TIR-v2a-mCherry: 
Forward_CCCTGCTTAACCGATTCCCAGGATAACTTTGTGTGGCCTGA 
Reverse_TCAGGCCACACAAAGTTATCCTGGGAATCGGTTAAGCAGGG 
pMiddle-mito-mCherry: 
Forward_GGGGACAAGTTTGTACAAAAAAGCAGGCTTTATGTCTGGACT
TCTGAGGGGA 
Reverse_GGGGACCACTTTGTACAAGAAAGCTGGGTACTACTTCTTTTGT
GGCTCTTTTT 
Overlap of mitochondria and mCherry: 
Forward_GCCACCGCGGCCGCCATGGTGAGCAAGGGC 
Reverse_GCCCTTGCTCACCATGGCGGCCGCGGTGGC 
pMiddle-Kaede: 
Forward_GGGGACAAGTTTGTACAAAAAAGCAGGCTCAGCCACCATGGT
GAGTCTGATTAAACCAG 
Reverse_GGGGACCACTTTGTACAAGAAAGCTGGGTACTACTTACTTGA
CGTTGTCCGGCA’ 
pMiddle-Synapsin1: 
Forward_GGGGACAAGTTTGTACAAAAAAGCAGGCTCAGCCACCATGA
ATTACCTGCGACGTCGA 
Reverse_GGGGACCACTTTGTACAAGAAAGCTGGGTACTACTTCCACGG
AGAAGAGGCTTG 
p5E-mfap4: 
Forward_GGGGACAACTTTGTATAGAAAAGTTGTTGCGTTTCTTGGTACA
GCTGGA 
Reverse_GGGACTGCTTTTTTGTACAAACTTGCCACGATCTAAAGTCATG
AAG 
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pMiddle-mitoRGECO: 
Forward_GGGGACAAGTTTGTACAAAAAAGCAGGCTTTATGTCTGGACT
TCTGAGGGGA 
Reverse_GGGGACCACTTTGTACAAGAAAGCTGGGTTCTACTTCGCTGTC
ATCATTTG 
pMiddle-erGCaMP3a: 
Forward_GGGGACAAGTTTGTACAAAAAAGCAGGCTTTATGGAACACAG
CGGGATTCTG 
Reverse_GGGGACCACTTTGTACAAGAAAGCTGGGTTCTACTTCGCTGTC
ATCATTTG 
pMiddle-ratTRPV1-tgRFP: 
Forward_GGGGACAAGTTTGTACAAAAAAGCAGGCTCAGCCACCATGG
AACAACGGGCTA 
Reverse_GGGGACCACTTTGTACAAGAAAGCTGGGTACTACTTCTTTTGT
GGCTCTTTTT 
3.4 Plasmids construction 
BP reaction for cloning the PCR products into the pDonors: (Dilute the PCR 
products and pDonor vectors to 50 fentmole with TE buffer, pH 8.0) 
50 fentmole (fm) = 1000 bp / 33 ng 
For 10 μL BP reaction: 
 
pDonor middle (5’E), 50 fm 1 μL 
PCR product, 50 fm 1 μL 
TE buffer, pH 8.0     6 μL 
BP enzyme     2 μL 
The reaction was incubated at 25°C for 1 hour. Then, the reaction was stopped by 
incubating with 1 μL Proteinase K for 15 mins at 37°C. Afterwards, 2 μL of BP 
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reaction was transformed into DH5α competent cells, which were cultured in 
kanamycin resistant plate. 
The positive pMiddle-target gene vectors were confirmed by sequencing with M13 
Fwd or/and M13 Rev primers. 
Next, the LR reaction was performed to get the Tol2 constructs: (Dilute all the 
needed vectors to 20 fentmole with TE buffer, pH 8.0) 
For 10 μL LR reaction: 
 
Destination vector, pDonor, 20 fm 1 μL 
Entry vector 1, p5E (SILL, UAS, or mfap4), 20 fm 1 μL 
Entry vector 2, p3E (poly (A) or mCherry or RFP), 20 fm   1 μL 
Entry vector 3, pMiddle (for example: Sarm1-v2a-mCherry or 
mitoRGECO), 20 fm  
1 μL 
TE buffer, pH 8.0     4 μL 
LR clonase™ II enzyme    2 μL 
The LR reaction was incubated at 25°C for 1 hour. Then, the reaction was added 1 
μL Proteinase K for digestion 15 mins at 37°C. Afterwards, 2 μL of reaction was 
transformed into TOP10 competent cells. Then, the cells were cultured in 
kanamycin resistant plate. 
The positive colonies were confirmed by restriction enzyme digestion.  
3.5 Sarm1 mutagenesis 
1. Prepare the sgRNA and Cas9 
1) sgRNA  
a. Clone the sgRNA construct 
    The oligonucleotides of sgRNA were designed on the website. First, I 
screened the first exon of sarm1 with the on-line tool “ZiFiT Targeter software 
package” (http://zifit.partners.org) (Wright et al., 2006). The target sequence 
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5’-GGGACTTGGAAGAGACCCGC-3’ was selected to clone into the sgRNA 
transcription construct, pDR274.  
The oligonucleotides were annealed at 95°C for 10 mins. Then the 
oligonucleotides were kept at room temperature for 2 hours. Before ligation, the 
annealed oligonucleotides were digested with BsaI for 30 mins at 37°C. The 
vector, pDR274 had already been linearized with BsaI and was purified with 
QIAquick Gel Extraction kit. After 10 mins ligation with the T4 ligase, 5 μL of 
the ligated product was transformed into DH5α Competent Cells, and was 
cultured in Ampicillin resistance plate. The correct constructs were confirmed 
by sequencing. 
The reaction for restriction enzyme digestion:  
2-5 μg DNA or 20 μL annealed oligos, 5 μL 10x buffer, 10 units Fast digestion 
Enzyme, ddH2O up to 50 μL. 
The digestion was incubated at 37°C for 0.5-1 hour. Then, the enzyme was 
inactivated at 85°C for 10 mins. The digested DNA was purified by gel 
electrophoresis.  
T4 ligation system (10 μL):  
1 μL annealed oligos, 1 μL linearized pDR274, 1 μL 10x T4 buffer, 0.5 μL T4 
ligase, 6.5 μL ddH2O, incubated at room temperature for 10 mins. 
b. In vitro transcript, sgRNA 
    The constructs which had already incorporated the sgRNA target sequence 
were linearized with DraI for 3-4 hours at 37°C. Then, the purification was done 
with the QIAquick Gel Extraction kit. For in vitro transcript, 200 ng linearized 
plasmid was used for the T7 promotor transcription system. 
In vitro transcript system (20 μL):  
2 μL T7 10x buffer, 2 μL T7 ATP, 2 μL T7 CTP, 2 μL T7 GTP, 2 μL T7 UTP, 
200 ng linearized plasmid, 2 μL T7 Enzyme mix, up to 20 μL with Nuclease-
Free water, and incubated at 37°C for 2 hours.  
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Next, the template DNA was digested with 1 μL TURBO DNase at 37°C for 15 
mins. Finally, the sgRNA was purified with the RNA easy kit and was kept at -
80°C.  
2) Cas9 mRNA or Protein 
a. Cas9 mRNA 
The vector for producing Cas9 mRNA, pMLM3613, was linearized with 
PmeI and was purified with QIAquick Gel Extraction kit. The linearized 
pMLM3613 was used as the template to transcript the Cas9 mRNA with 
mMESSAGE mMACHINE T7 kit. 
The reaction system for mRNA transcription (20 μL): 
2 μL 10x T7 reaction buffer, 10 μL T7 2x NTP/ARCA, 2 μg Linearized 
template, 2 μL T7 Enzyme mix, up to 20 μL with Nuclease-Free water, and 
incubated at 37°C for 2 hours. 
Next, the template DNA was digested with 1 μL TURBO DNase at 37°C for 15 
mins. 
Then, poly (A) tailing reaction was used to add poly (A) to the mRNA. 
The reaction system for adding poly (A) (100 μL): 
20 μL mMESSAGE mMACHINE reaction, 20 μL 5XE-PAP buffer, 10 μL 
MnCl2 25 mM, 10 μL ATP 10 mM, 4 μL E-PAP, up to 100 μL with Nuclease-
Free water, incubated at 37°C for 1 hour. 
The mRNA was purified with the RNA easy kit and was kept at -80°C.  
b. Cas9 protein 
The Cas9 protein was the commercial one from the company, PNA Bio, 
cat.no. CP01. 
2. Microinjection 
1) Mixture RNA: Cas9 mRNA 1500 ng, sgRNA 70 ng, added Nuclease Free water 
to 10 μL. 
MATERIALS AND METHODS 
40 
1-2 nL of mixture was injected into one-cell stage embryos. 
2) Mixture Cas9 protein: Cas9 protein 200 ng, sgRNA 100 ng, added Nuclease 
Free water to 10 μL. 
1-2 nL of mixture was injected into one-cell stage embryos. 
3. Screen the sarm1 mutants 
When the injected fish grew up to 2-3 months old, I did fin-cut and extracted the 
genome with REDExtrac-N-AmpTM Tissue PCR Kit, including the following 
buffers: Extraction Solution, Tissue Preparation Solution, Neutralization Solution 
B. 
The procedure was following: suspended the samples with 50 μL Extraction 
Solution, then added 12.5 μL Tissue Preparation Solution and mixed well, 
incubating at 95°C for 10 mins. Next, added 50ul Neutralization Solution B and 
mixed well for centrifuging the samples at room temperature with 12000 rpm for 5 
mins. Then, 2 μL of the medium was taken as the template for PCR (Polymerase 
chain reaction). 
The PCR system (50 μL): 
5 μL 10x buffer, 3 μL 2.5mM dNTP, 1 μL genotyping forward primer, 1 μL 
genotyping reverse primer, 2 μL template, 0.2 μL Taq Enzyme, 37.5 μL ddH2O up 
to 50 μL. 
Setup for the PCR steps: 
95°C     3 mins for initial denaturation 
95°C     30 sec for denaturation 
60°C     30 sec for annealing                  35 cycles 
72°C     35 sec for elongation 
72°C     10 mins for final elongation 
4°C       Holding 
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Purified the PCR product and sequenced the PCR fragment with the forward 
primer. The positive fish with mutations was crossed with wild type ones or desire 
lines for the next generation. 
Finally, I obtained germ-line transmission of two independent alleles: sarm1hzm13 
and sarm1hzm14. 
3.6 Transgenic lines 
1. Prepare the transposase mRNA and Tol2 constructs  
1) transposase mRNA 
The vector for transposase mRNA, pCS2+-Tp Transposase, was linearized 
with NotI and was purified with QIAquick Gel Extraction kit.  
The transcription was done with mMESSAGE mMACHINE SP6 kit. 
The reaction system for mRNA transcription (20 μL): 
2 μL 10x SP6 reaction buffer, 10 μL SP6 2x NTP/ARCA, 2 μg Linearized 
template, 2 μL SP6 Enzyme mix, up to 20 μL with Nuclease-Free water, and 
incubated at 37°C for 2 hours. 
Next, the template DNA was digested with 1 μL TURBO DNase at 37°C for 15 
mins. 
The mRNA was purified with the RNA easy kit and was kept at -80°C.  
2) Tol2 constructs 
The details of these two constructs, mfap4:EGFP-CAAX and 
SILL:ratTRPV1-tagRFP were section 3.3. 
2. Microinjection 
      The concentration was 12.5 ng/μL of both DNA and mRNA, diluting in RNase-
free water.  
      To make transgenic lines, 25 pg of Tol2 donor plasmid and 25 pg of transposase 
mRNA were injected into one-cell stage embryos. 
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3. Screen the transgenic fish 
30-60 embryos (F0) were selected with correct expression of the desire constructs, 
then the embryos were maintained in the fish facilities; 
F1 founders were getting by outcrossing the F0 ones with the Tg[Casper] strain; 
F2 embryos from F1 adults were used to do experiments. The F2 inherited stable 
transposons in a Mendelian fashion. This helped to evaluate for proper expression 
based on the promoter used within the injected transposon.  
3.7 Immunostaining 
Procedure of immunostaining 
1) Fixed the larvae with fresh 4% PFA which was dissolved in PBS (phosphate-
buffered saline buffer); 
The larvae with indicated dpf (days post fertilization) were anesthetized with 
Tricaine (MS-222) (0.016% M/V) in Danieau’s (1X, 5 mM NaCl, 0.17 mM KCl, 
0.33 mM CaCl2, 0.33 mM MgSO4, dissolved in 1 L deionized water). Then, the 
larvae were fixed with 4% PFA and incubated at 4°C overnight. 
2) Penetrated the sample with pre-cold acetone or digested with Proteinase K; 
For samples which were stained with Claudin-k (diluted 1:500) and 6D2 antibodies 
(diluted 1:5);  
The samples were washed at room temperature (RT) with PBST (0.2% Tween 
20) three times (10mins per wash) after fixation. Then, the samples were 
incubated in pre-cold acetone 6-10 mins at -20°C. Next, the samples were 
transferred into ddH2O at RT for 5 mins. Finally, the samples were washed with 
PBST for 10 mins at RT. 
For samples which were stained with Acetylated tubulin antibody (diluted 1:1000); 
The samples were washed at RT with PBST (0.2% Tween 20) three times (10 
mins per wash) after fixation.  
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Firstly, the samples ware dehydrated with gradient solutions (RT, 5 mins per 
step): 25% methanol (in PBST), 50% methanol (in PBST), 75% methanol (in 
PBST), and 100% methanol with twice. Then, the samples should be kept at -
20°C for at least 1 hour;  
Secondly, the samples were rehydrated with the gradient solutions (RT, 5 mins 
per step): 75% methanol (in PBST), 50% methanol (in PBST), 25% methanol 
(in PBST), and PBST with twice. Then, the samples were digested with 10 
μg/mL final concentration of Proteinase K solution. For 3 dpf larva, the 
digestion time was 20 mins. For 4 dpf larva, the time was 30 mins. For 5 dpf or 
6 dpf, the digestion time was 30 mins with 20 μg/mL final concentration of 
Proteinase K; 
Thirdly, the digested reaction was stopped by incubating the samples in 4% 
PFA at RT for 20 mins; 
Finally, the samples were washed with PBST for three times (5 mins per wash). 
3) Blocking the samples with 10% bovine serum albumin (BSA, Sigma A4612) which 
was diluted with PBST at RT for 2 hours or longer; 
4) Incubated the samples with indicated primary antibodies overnight at 4°C; 
The antibodies were diluted in the blocking buffer (10% BAS in PBST). When 
the incubating was done, the samples were washed with PBST for 2 hours 
(changing the PBST every 30 mins). 
5) Incubated the samples with secondary antibodies (diluted 1:200) at 4°C overnight 
(avoiding light); 
The secondary antibodies were diluted in the blocking buffer (10% BAS in PBST). 
When the incubating was done, the samples were washed with PBST for 3 times, 
20 mins per wash. 
6) Kept the samples in VectaMount® Permanent Mounting Medium at 4°C or 
mounted the samples with 0.8% low melting-point agarose on a 35 mm glass-
bottom Petri dish for imaging with the laser-scanning confocal microscope (LSM 
510, Carl Zeiss) or the spinning disc confocal microscope (Carl Zeiss).  
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3.8 Intravital microscopy 
1. Samples preparation 
The larvae with indicated fluorescence were screened with a fluorescence 
stereomicroscope. Then, the samples were anesthetized with Tricaine and were 
mounted in 0.8% low melting-point agarose on a 35 mm glass-bottom Petri dish. 
The position of the samples was adjusted by the hair-loop glued to the tip of a glass 
pipette.  
2. Videomicroscopy 
a. The Petri dish was loading on the holder of spinning disc microscope. The 
holder was keeping at 28.5°C with the heating system (Xiao and López-Schier, 
2016). The samples were checked with 40x air objective or 60x water-immersed 
objective (for time lapse imaging, changed the water with the oil for 60x water-
immersed objective).  
b. For the video imaging, the interested region was in the central of focus. Then, I 
set up the top and down boundaries of the images to scope the whole axons 
or/and Schwann cells. This was the Z-stacks of the images. When Z-stack was 
ready, the intervals of one stack were set to 0.8 – 1.5 µm. The exposure time of 
the 488 nm laser for green or 561 nm laser for red were adjusted to 400 ms or 
600 ms. Time intervals were 10 minutes or 15 minutes per frame. The whole 
video imaging can be 12 hours or 24 hours. 
3.9 Western blot assay 
1. Buffers and Equipment; 
SDS-PAGE: Hand-made 12%  
(5 mL Separating gel: ddH2O 1.65 mL, 1.5 M Tris pH 8.8 1.25 mL, 30% AB 2 mL, 
10% SDS 50 uL, 10% AP 50 uL, TEMED 2 uL;  
2 mL Stacking gel: ddH2O 1.4 mL, 1.0 M Tris pH 6.8 0.25 mL, 30% AB 0.5 mL, 
10% SDS 20 uL, 10% AP 20 uL, TEMED 2 uL) 
Running buffer (1 L): Tris 3 g, Glycine 18.8 g, SDS 1 g, dissolved into 1 L ddH2O. 
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Transfer buffer (1 L): Tris 3.03 g, Glycine 14.3 g, dissolved into 800 mL ddH2O, 
then added 200 mL methanol to 1 L, kept at 4°C. 
Protein electrophoresis equipment: BIO-RAD, Mini-PROTEIN® System 
2. Procedure of the Westernblot 
1) Prepare the sample: 
5 dpf larvae were anesthetized with Tricaine in the tubes. 5 mins later, the 
Tricaine was aspirated; 
200 μL of RIPA buffer (pre-cold on ice, with Protease inhibitor cocktail (one 
plate for 50mL buffer) was added, then the samples were homogenized 
carefully with tips; 
The tubes were putted on ice for further lysis. 20 mins later, the tubes were 
centrifuged in the tabletop microcentrifuge at 12000 rpm, 4°C for 10 mins. 
Then, the supernatant was transferred to a new tube; 
The protein was measured with BCA assay; 
The supernatant was diluted with loading buffer and boiled at 99°C for 5 
minutes. 
2) Performed the SDS-PAGE and membrane transfer: 
Loaded 20 ng proteins for performing the SDS-PAGE and set the voltage to 50 
V for samples through the stacking gel, then set 100 V to the separating gel; 
The proteins were transferred into PVDF membrane at 100 V for 90 mins (The 
PVDF membrane should be pre-soaked with methanol and the whole 
transferring box should be kept at 4°C). 
3) Primary antibody incubation: 
The membrane was rinsed with PBST and blocked with 5% skimmed milk 
(diluted with PBST) for one hour at room temperature; 
Then, the membrane was incubated with primary antibodies, (rabbit anti-
Sarm1, 1:500; mouse anti-β-tubulin, 1:2000), at 4°C overnight. 
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4) Secondary antibody incubation: 
After the primary incubation, the membrane was quickly washed with PBST at 
RT, 3 times, 10 mins per wash; 
Then, the membrane was incubated with secondary antibodies (Peroxidase-
Affini Pure Goat Anti-Mouse IgG (H+L), 1:10000; Peroxidase-Affini Pure 
Goat Anti-Rabbit IgG (H+L), 1:10000) at RT for 1 hour 
5) Developing: 
The secondary antibodies were washed quickly with PBST, 3 times, 15 mins 
per wash; 
Then, the membrane was incubated with mixed ECL buffer (Buffer A: peroxide 
solution; Buffer B: luminol enhancer solution) for 1-2 mins; 
Finally, the membrane was put into the equipment for getting the images.  
3.10 Laser microsurgery 
1. Samples preparation: 
The larvae with injected constructs or from crossed directly were anesthetized and 
were screened for the positive ones. Then, anesthetized larvae were mounted with 
low melting-point agarose in the Petri dish, which was loaded to the platform of 
spinning disc microscope for laser microsurgery. 
2. Microsurgery: 
The laser system for microsurgery is from Roper scientific AS. It is set up with an 
ultraviolet laser using the iLasPulse system and is compiled into the software, 
VISION, for further manufacturing. The laser is 350 nm, and with 400 ps/2.5 uJ per 
pulse (Pujol-Martí et al., 2014; Xiao and López-Schier, 2016; Xiao et al., 2015b)  
Then, the samples were checked with 63x water-immersion objective (the laser 
beam works in 63x objective) and the interesting region for surgery was selected; 
Next, the laser pluses were calibrated and adjusted the power to 27 mW with the 
control panel; 
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A rectangle region was selected for transection. The pulse was 0.05 ms performing 
and 3 times/mouse click. To fully sever the axons, the laser pulses should be applied 
repeatedly until it was a clear gap in the rectangle region. Then, the rectangle region 
was moved to the next position. The samples were observed again one hour later to 
confirm that the axons were completely transected.  
3.11 Chemogenetic approach 
1. Samples preparation: 
For chemogenetic experiments, the UAS: ratTRPV1-tagRFP was used to response 
the capsaicin for calcium channel control. 
The embryos from Tg[UAS:GCaMP7a] were co-injected the two constructs,  
SILL:Gal4 and UAS : ratTRPV1-tagRFP. The positive larvae were selected under 
fluorescence stereomicroscope at 4 dpf. 
2. Calcium channel manipulating: 
For activating the TRPV1 channel, I used 2 μM capsaicin final concentration in the 
experiment.  
Then, the larva was mounted in the dish which was loaded on the holder of spinning 
disc; 
The region for imaging was selected for imaging (the 63x water-immersion 
objective with an exposure time of 400 milliseconds. The imaging was taken by 
two channels (488 nm for GCaMP7a and 561 nm for TRPV1-tgRFP labeled axons) 
and was lasting for one hours with 2 or 3 mins per frame.    
The capsaicin was added into the medium up to 2 μM final concentration at 20 mins 
after imaging started.  
Ablation the axons in Sarm1 mutant: 
Sarm1 mutant larvae, the HGn39D with SILL-Gal4; UAS: mCherry or SILL-Gal4; 
UAS: ratTRPV1-tagRFP positive animals were axotomized by the laser.  
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2 hours after axons transection, the larvae were treated with 10 μM capsaicin or 
ethanol (1:1000, V/V). 1.5 hours after capsaicin treatment, images were taken by 
spinning disc microscopy.  
3.12 Electrophysiological recordings 
(This protocol is from Melanie Haehnel-Taguchi.) 
1. Samples preparation: 
4-5 dpf larvae were anaesthetized in 0.03% Tricaine solution and paralyzed in 0.1% 
α-bungarotoxin (Molecular Probes);  
Samples were rinsed and mounted laterally with tungsten pins on Sylgard lined 
dishes. 
2. Preparation for recording: 
Recordings were performed as previously described in the paper (Haehnel-Taguchi 
et al., 2014), with some modifications. 
a. Recordings of action potentials in lateralis afferent neurons were made in 
extracellular solution (NaCl 134 mM, KCl 2.9 mM, MgCl2 1.2 mM, HEPES 10 
mM, Glucose 10 mM, pH 7.8, osmolarity 290 mosM), under an Axioskop 
microscope (Zeiss) modified to a fixed-stage set-up, using DIC optics; 
b. Action potentials were recorded in loose patch configuration from afferent 
neurons of the posterior lateral line with borosilicate glass pipettes pulled 
(Sutter P-2000) to a resistance of 3.5-6 MΩ in extracellular solution.   
c. Data were acquired with a Multiclamp 700 B amplifier and a Digidata 1440 A 
digitizer using pClamp10 software (Molecular Devices). 
3. Electrophysiological recording: 
1) Recordings were made in current clamp mode, sampled at 20 kHz and filtered 
at 1 kHz. Direct mechanical stimulation of hair cells was achieved using a 
water jet from a glass micropipette (tip diameter~30 µm) driven by a pressure 
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pump (ASI MPPI-3) triggered by a voltage output signal from the Digidata 
1440 A; 
2) The stimulation pipette was positioned parallel to the fish trunk along the 
midline in proximity to a neuromast. Neuromasts were sequentially stimulated 
with a test pulse until an evoked response was detected; 
3) Once a response was detected, 20 pressure pulses were applied during 5 
seconds long sweeps, with one-second delay and 100-millisecond duration; 
4) Spontaneous spike rate was recorded before stimulation during 12-120 
seconds. Spike rate before each stimulus was calculated during the first 200 
milliseconds of a recording sweep and evoked spikes were calculated from 
spikes during 200 milliseconds after stimulus onset; 
5) Latency was measured as the first spike after stimulus onset. Spike rate and 
latency were averaged from 20 stimulations for each recording; 
6) Spike detection from recordings was done in DataView (Version 11.0, W. 
Heitler, University of St. Andrews) by setting a negative threshold at 4X the 
standard deviation of the first 1000 milliseconds of the recording; 
7) Further data analysis and statistics were performed using Matlab (Version 8.6 
R2015b). 
3.13 Behavioral assays 
1. Touch invoked escape response: 
a. Samples preparation: 
2 dpf embryos were gently dechorionated and were kept in Danieau’s solution 
at 28ºC for at least 1 hour before experiment.  
b. Recording the behavior of larvae under stimulation: 
Embryos were placed into a flat uncovered Petri dish containing Danieau’s and 
were recorded with a high-speed camera (NX4 series, Imaging solution, 
GmbH);  
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Video recording was launched and a randomly chosen embryo was touched 
with a blunt glass needle until it evoked a reaction. Recordings were done under 
white-light illumination over 150 seconds at a rate of 200 frames per second 
(fps);  
The swimming trajectories were obtained with 3D Particle Tracker plugin, 
ImageJ software. The further quantification and statistics were performed by 
Python.  
2. Rheotaxis experiments (Asgharsharghi, 2019): 
(This setup was designed and was assembled by Amir Asgharsharghi Bonab. I 
performed the experiments under Amir’s supervision. Amir got the data from the 
recording videos. I plotted the results and performed the statistical test.) 
a. Setup for recording the Rheotaxis: 
The behavioral rig is designed to evaluate zebrafish orientation to the direction 
of water flow under laminar conditions in darkness and in isolation from 
significant environmental noise, as described in Amir’ preparing paper, 
Mechanosensory Control of Rheotaxis in Larval Zebrafish. The rig is 
constructed of a Plexiglas® pipe with inner diameter of 2.4 cm filled with the 
water. One side of the pipe is connected to the water reservoir and in the other 
side is the plunger connected to the motor shaft. Movement of the motor shaft 
displaces the plunger back and forth causing the water flow inside the tube. The 
rig was illuminated with an infrared light-emitting diode (LED) array (IR: 940 
nm). Images of fish movement were captured with a high-speed camera (NX4 
series, Imaging solution, GmbH) at 200 frames per second (fps). Captured 
images were saved on the computer hard drive for further analysis.  
b. Samples preparation: 
The fish for rheotaxis assay were 7 dpf larvae. Here, I prepared the fish with 
following groups (for WT and Sarm1-/-); 
intact 7 dpf larva, sham ablation larva, 3 days recovery larva (ablation at 4 dpf), 
and one day recovery larva (ablation at 6 dpf). 
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Ps: ablation group indicated that all the axons of one side lateral line was cut 
(including the anterior and posterior neurons), following the protocol of laser 
microsurgery.  
c. Recording the larva behavior: 
For rheotaxis recording, the fish was placed and was kept in the rig for at least 
30 mins prior to do the experiment; 
Set the speed of the motor to 6 mm / sec. When the fish was closed to the plunger 
and was with a long distance for swimming, I started to record and pushed the 
motor movement; 
For each fish, there were 10 trails done with 5-10 mins interval for fish adapting 
to the environment; 
Animal tracking and orientation analysis were done using the Bonsai software; 
The orientation of the fish relative to flow direction was used to derive a 
rheotactic performance. 
3.14 Quantification of mitochondrial density and motility 
1. Imaging   
a. For imaging the mitochondria in the axons, I injected the SILL:mito-mCherry 
into the embryos from WT or Sarm1-/- to label the single axon with mito-
mCherry. 
b. The imaging was done with the 63x water immersion objective. Each imaging 
was 3 mins-long with one second interval.  
2. Quantification 
a. For density quantification, images were inverted to black and white. Then, I 
used the Fiji software (http:fiji.sc) to calculate the area of the signal. 
b. For movement quantification, the plugin, Multi-Kymograph was used to 
generate kymographs of mitochondrial movement; 
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The movement of mitochondria was determined by the slope of lines drawn 
over time, and the direction of movement was determined by the moving 
mitochondria crossing the time line (vertical) in the kymographs; 
The data were analyzed with the Graphpad Prism software. 
3.15 Calcium imaging and quantification 
1. Imaging  
a. For calcium imaging in lateralis neurons, Tg[SILL:Gal4; UAS:GCaMP7a]  
double-transgenic larvae were anesthetized and were mounted in 0.8% low 
melting-point agarose on a 35mm glass-bottom Petri dish.  
b. Imaging was acquired through a 63x water-immersion objective with an 
exposure time of 400 milliseconds. Laser-mediated axon transection was done 
after the fourth imaging of time series. Next, the videomicroscopy was done for 
2 minutes at a frame rate of 400 milliseconds at 28.5°C.  
2. Calcium signal quantification 
To quantify the calcium signal, images were processed in ImageJ. The region 
of interest (ROI) was selected and the density of ROI was measured. GCaMP 
or RGECO intensity changes were calculated as follows: ΔF/F0 = (F–F0)/F0, 
where F0 is the value of the fluorescent signal before axons transected, and F is 
the value of the fluorescent signal with time point after axon severing (Esterberg 
et al., 2016). 
3.16 Statistical analysis 
The Student’s t-test (two tailed), T-test (Turkey test), ANOVA test, and Wilcoxon rank 
sum test were applied using Graphpad prism or SigmaPlot software. Error bars in all 
figures are standard errors of the mean (SEM). 
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4. Results 
4.1 Identification and mutagenesis of Sarm1 in zebrafish 
Sarm1 (Sterile Alpha and TIR Motif containing 1) has one MTS (mitochondria target 
sequence) in the N terminal, followed by two SAM (sterile α motif) domains and one TIR 
(Toll-interleukin-1 receptor) domain in mouse and human. The amino acid sequence of 
Sarm1 is conserved across species (Osterloh et al., 2012). To identify Sarm1 orthologous 
in zebrafish, I screened the publicly accessible genomic data (Danio rerio reference 
genome assembly version GRCz11) by blasting the TIR domain which is present in all 
known Sarm1 and the Toll-like receptor family proteins. There was only one candidate 
sarm1 gene in zebrafish genome, which locates on the chromosome 15 and contains 8 
exons that code for a protein consisting of 713 amino acids. Then, I compared the amino 
acid sequence of zebrafish Sarm1 to the orthologs in human, mouse, and Drosophila. The 
two SAM domains and the TIR domain are conserved in these species. However, I did not 
find the potential mitochondrial targeting sequence in zebrafish Sarm1 by aligning the N 
terminal of Sarm1 to mitochondrial located zebrafish proteins, such as COX4I1 
(zgc:110058), VDAC1 (zgc:85830) and TOMM20b (zgc:92628). This indicates that Sarm1 
lacks an obvious mitochondrial target sequence (Figure 4.1 A and B).  
To study the function of Sarm1 in zebrafish, I generated loss-of-function mutations in 
Sarm1 gene with CRISPR/Cas9 mediated genome modification. The CRISPR tool is user-
friendly and highly efficient for genome editing in zebrafish. A single guide RNA was 
designed to target the fiftieth amino acid of the sarm1 protein, which is located in the first 
exon (Figure 4.1C). To obtain a mutant zebrafish, I screened the F1 generation fish by 
sequencing. F1 generations were obtained by crossing the mutation carriers of F0 (injected 
ones) generation with Tg[HGn39D] line, in which lateralis afferent neurons are marked 
with GFP. I identified germline transmission of two alleles: sarm1hzm13 and sarm1hzm14. The 
hzm13 allele introduces with 11-base deletion and T/C mutation, resulting in a frame shift 
and premature stop codon generating a truncated protein lacking all the SAM and TIR 
domains. The hzm14 harbors a 7-base deletion and AG/GA mutation that generates a frame 
shift and premature stop codon (Figure 4.1 D).  
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To confirm the absence of Sarm1, I performed Western-Blots with the lysate from 4 dpf 
(days post fertilization) wild type (WT) and Sarm1hzm13 larvae, respectively. The 
commercial Sarm1 antibody recognizes the C terminal of Zebrafish Sarm1. The blots 
showed one single band approximately to 80KD in the WT that was consistent to the 
expected size of sarm1 protein in the SDS-PAGE, but I did not detect any band of a 
comparable size on the lane with the protein extract from Sarm1hzm13 (Figure 4.1E). Taken 
together, two mutant alleles of Sarm1 have been successfully generated with CRISPR/Cas9 
(Tian et al., 2020). 
 
Figure 4.1 Identification and mutagenesis of Sarm1 in zebrafish. A) Genomic structure of sarm1 
gene in Danio rerio, indicating 8 exons, with protein coding-regions in grey, non-coding region in white, 
and introns as bent lines (not in scale). B) Alignment of the Sarm1 functional domains from different 
species, the MT (mitochondrial targeting sequence) is conserved in mouse and human, the two SAM 
domains and one TIR domain are conserved in all these species. C) Structure of the zebrafish Sarm1 
protein highlighting the two SAM domains (dark grey), the TIR domain (light grey). The downward 
arrow indicates the region targeted for mutagenesis (sgRNA target site), approximately 50 amino acids 
from the start codon. D) Sequence of the WT and Sarm1 mutants, the mutagenized region is indicated 
in red. The hzm13 allele introduces an 11-base deletion and T/C mutation, resulting in a frame shift and 
premature stop codon. The hzm14 allele is a 7-base deletion and AG/GA mutation that also generates a 
frame shift and premature stop codon. E) Western blots of protein extracts from WT and Sarm1hzm13 
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fish embryos with a commercial antibody which recognizes the N-terminal of Sarm1, revealing absence 
of the protein in the Sarm1 mutants. Blot of the expression of tubulin is the loading control (modified 
from Tian et al., 2020). 
4.2 Sarm1 is dispensable for the development and maintenance of a 
sensorineural pathway 
To assess the effects of absence of Sarm1 in the nervous system, I examined several 
parameters of neuronal structure and circuit function by combining sarm1hzm13 (hereafter: 
Sarm1-deficient or Sarm1-/-) with various transgenic lines, expressing fluorescent markers 
in the afferent neurons of the mechanosensory lateral line, as well as in their associated 
Schwann cells (Ghysen and Dambly-Chaudière, 2007; Lopez-Schier and Pujol-Martí, 
2013). The zebrafish lateral-line system is ideal for in vivo studies at high-resolution over 
extended periods, and for physiological studies under normal and altered conditions 
(Drerup and Nechiporuk, 2016; Haehnel-Taguchi et al., 2018; Pujol-Martí et al., 2014). It 
combines the organization of a typical vertebrate sensory system with the amenability for 
controlled experimental interventions that include microsurgery, pharmacology, and 
optogenetics (O'Donnell et al., 2013; Vargas et al., 2015; Xiao et al., 2015a). Additionally, 
the lateral line mediates a robust behavioral reaction to water currents called rheotaxis, 
which can be easily quantified by measuring the orientation of animals to the direction of 
water flow (Oteiza et al., 2017). 
Firstly, I found there were no obvious anatomical defects in the Sarm1-/-, including the size, 
shapes and locations of organs from the images of 5dpf wild type and Sarm1-/- zebrafish 
larvae with bright-field microscopy (Figure 4.2.1A). In the adult stage (around 3-4 
months), Sarm1-/- zebrafish were viable, normally developed and fertile, as compared to 
their WT siblings. Next, I performed immunostainings with an antibody that recognizes 
acetylated tubulin, which can be used to highlight axons and stain the whole nervous 
system in zebrafish and mammals. The structure of the nervous system showed no 
anatomical defects in the whole brain in 4 dpf Sarm1-/- larva, comparing to the WT. 
Moreover, the shape and the connections of neurons in the forebrain and midbrain showed 
no difference between WT and Sarm1-/- (Figure 4.2.1B).  
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To analyse the function of the nervous system in development, I examined the touch-
evoked escape response, a simple assay to monitor sensorimotor function that consists of 
eliciting the escape response after tactile stimuli (Sztal et al., 2016). The escapes were 
recorded with a high-speed camera when the 2 dpf larvae were stimulated with a tiny 
needle. The time-lapse images showed that the larvae escaped quickly when the needle was 
close to their bodies, and they preferred to swim to the opposite direction of the needle 
(Figure 4.2.1C). The quantification of swimming distance showed that the average of total 
distance was around 40 mm in both groups and there was no statistical significance (Figure 
4.2.1D). Acceleration of escape is used to measure the ability to swim immediately after 
stimulation (Burgess and Granato, 2007). My quantification showed that there was no 
statistical difference in acceleration between WT and Sarm1-/- (Figure 4.2.1E). Taken 
together, these results demonstrate that loss of function of Sarm1 impacts neither the neural 
development nor the growth of the zebrafish. Moreover, the neural wiring, especially the 
innervation between sensory neurons and muscle was not affected in Sarm1-/- zebrafish, as 
inferred from the normal escape response (Tian et al., 2020). 
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Figure 4.2.1 Overview and touch-evoked escape tests of wild type and Sarm1-/- zebrafish. A) Low-
magnification image showing the whole view of a WT 5 dpf zebrafish (top) and a Sarm1-/- (bottom), no 
overall anatomical differences. B) Confocal image of dorsal view of a WT 5 dpf zebrafish (left) and a 
Sarm1-/- (right) larva stained with an antibody against acetylated Tubulin to mark neurons in the central 
nervous system, showing no evident defects in the Sarm1-/-. In this and all figures, rostral is left and 
caudal is right. Scale bar 20 µm. C) Time lapse images showing the escape response behavior of 2 dpf 
larva upon stimulus; Up panels showing the escape of WT larva, down panels showing the escape of 
Sarm1-/- larva. Times are indicated in the upper-right of the images. D-E) Quantification of sensorimotor 
function in zebrafish; (D) shows the total distance traveled by larvae after touch-trigger escape response 
in WT (dashed blue bar) and Sarm1-/- (dashed magenta bar). (E) Dot-plot of the average acceleration of 
WT (blue) and Sarm1-/- (magenta) after tactile touch-induced escape response. Error bar = SEM; n.s. 
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means no significant difference, Student’s t-test. WT n = 21, Sarm1-/- n = 21 (modified from Tian et al., 
2020). 
Secondly, I examined the development of sensory neurons in Sarm1-/- zebrafish by 
combining it to the sensory neuron labeled transgenic line Tg[HGn39D]. In this transgenic 
line, all the peripheral sensory neurons which connect the sensory organs of the lateral line 
to the brain are labeled with green fluorescence protein. The confocal microscopy images 
showed that lateralis afferent neurons appeared of normal size and localization in the head, 
and were polarized correctly in WT and Sarm1-/-. Additionally, neuronal central projections 
along the length of the ipsilateral hindbrain in Sarm1-/- are structurally and numerically 
indistinguishable from age-matched WT controls (Figure 4.2.2A-B). High magnification 
images showed the lateralis neurons are projecting peripheral axons that arborize normally 
underneath the receptive peripheral organs called neuromasts. There was no difference 
between WT and Sarm1-/- zebrafish (Figure 4.2.2C-D). To explore the central part of 
sensory neurons, SILL:mCherry and SILL:Synapsin1-GFP were co-expressed to label all 
the neurons and synaptic vesicles in the lateral line. I observed a normal morphology and 
consistent distribution of synapsin1 in neurons of WT and Sarm1-/-. Quantification of the 
number of synapsin1 dots in the single neuron showed that there was no statistical 
significance between WT and Sarm1-/- (Figure 4.2.2E-G). These data suggest that the loss 
of Sarm1 does not affect the development and maintenance of the lateralis afferent neurons 
(Tian et al., 2020). 
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Figure 4.2.2 Sarm1 deficiency does not influence the development of zebrafish lateral line. A-B) 
Confocal image of a 5 dpf WT (A) and Sarm1-/- (B) larvae carrying the Tg[HGn39D] transgene to mark 
lateralis afferent neurons with GFP. The posterior lateral-line ganglion is indicated with a red arrowhead. 
The dotted box indicates an innervated neuromast (expanded in C and D). Scale bar 400 μm. C-D) 
Confocal image of the peripheral arborization of lateralis neurons in 5 dpf WT (C) and Sarm1-/- (D). 
Red arrows indicate the position of a neuromast from the dotted boxes in (A-B). E-F) Confocal images 
of the central arborization of lateralis neurons in 5 dpf WT (E) and Sarm1-/- (F). mCherry (red, labeling 
the branches of axons in central) and Synapsin1-GFP (green, showing the puncta of synapsin1) reveal 
normal arborization and pre-synaptic puncta in both cases. G) Quantification of the number of synapsin1 
puncta. Error bar = SEM; n.s. = no significant difference, Student’s t-test. WT n = 15, Sarm1-/- n = 15 
(modified from Tian et al., 2020). 
Thirdly, the electrophysiological activity of the ganglion cells of sensory nerve under water 
stimulation was examined by Dr. Melanie Haehnel-Taguchi from University of Freiburg. 
The loose patch recordings of the lateralis afferent neurons under a 100-millisecond 
mechanical stimulation of neuromasts with a water jet showed spontaneous and evoked 
neuronal activity for 5 seconds in Sarm1-/- and control larvae (Figure 4.2.3A). Although, 
the general spontaneous spike rate and spike amplitude of lateralis afferent neurons varied 
across recording, it appeared that spike amplitude was lower in Sarm1-/- compared to 
controls. Raster plots from two stimulus protocols in control and Sarm1-/- larvae showed 
that both groups reliably responded to repeated stimulation (Figure 4.2.3B). For each 
recorded neuron, the stimulus was presented 20 times. The spontaneous spike rates of 
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lateralis neurons which showed the average records over 12 seconds to 2 minutes was not 
significantly different when comparing the WT and Sarm1-/- (Figure 4.2.3C). Moreover, 
there was no statistical significance in the latency of response onset upon stimulation 
between WT and Sarm1-/-, although the average latency time was slightly longer in WT 
(Figure 4.2.3D). In addition, both Sarm1-/- and WT responded with a significant increase 
in the spike rate to mechanical stimulation. The spike rate was around 3-folds increased in 
evoked condition than no stimulation; however, there was no statistical significance of with 
or without stimulation between Sarm1-/- and WTs (Figure 4.2.3E). Next, I wondered 
whether these mild differences of neuronal activity would impact the behavioral reaction 
of the fish to water flow that is mediated by the lateral line. To answer this question, I 
conducted a rheotactic assay by exposing the larval zebrafish to 6mm/s laminar water flow. 
For each larva, I performed more than 10 repeats in order to obtain the convincing results. 
The analysis and statistic quantification of the orientation of the fish to the direction of 
water flow was performed with the help of my colleague, Mr. Amir Asgharsharghi Bonab. 
The scope of cosine of orientation was similar in both WT and Sarm1-/-, which varied from 
0.82 to 1.00. However, the rheotaxis of normal specimens showed no statistical 
significance with the Sarm1-/- zebrafish from the Wilcoxon rank sum test (Figure 4.2.3F).  
Taken together, the above results indicate that systemic loss of Sarm1 is compatible with 
life, normal growth, reproduction, and nervous system development and function in 
zebrafish. 
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Figure 4.2.3 In vivo electrophysiological analysis of lateral neurons in wild type and Sarm1-/- 
zebrafish. A) Examples of five seconds long loose patch recordings of WT and Sarm1-/- larvae. Stimulus 
(water jet): 100 ms. B) Raster plots of the recorded response from two stimulus protocols. For each 
recorded neuron stimulus was presented 20 times. Blue: control, magenta: Sarm1-/-. C) Spontaneous 
spike rates from recorded neurons, averaged over entire recording (12 seconds to 2 minutes). Data 
obtained from n = 7 controls, n = 7 Sarm1-/-. No significant difference between control and Sarm1-/-. D) 
Latency of response onset after stimulus presentation from control and Sarm1-/- larvae. Responses were 
obtained from n = 4 controls and n = 5 Sarm1-/-. Individual data points represent the average from 20 
responses. Filled data points represent mean responses from experimental group. Error bar: standard 
deviation. No significant difference between control and Sarm1-/- group. E) Spike rates before and in 
response to stimulus. Significant difference for both groups between spike rate before stimulus and after 
stimulus presentation (calculated over 200 ms before and after stimulus). F) Rheotaxis (oriented 
swimming against water-flow direction) shown as cosine of the orientation from WT and Sarm1-/- larva 
in 6 mm/s water flow, showing a marginal difference between WT and Sarm1-/-. p = 0.117 was 
conducted by Wilcoxon rank sum test. WT n = 7 Sarm1-/- n = 7, 10 trails for each larva (modified from 
Tian et al., 2018). 
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4.3 Sarm1 deletion does not affect the number and the movement of 
mitochondria in the posterior lateral-line sensory neurons 
To assess neuronal intracellular dynamics, I marked the mitochondria of sensory neurons 
with SILL:mitoCherry, in which the mitochondrial targeting sequence was cloned from 
zebrafish Cytochrome-C oxidase subunit 8A gene (Jung Kim et al., 2008). I chose 
mitochondria because they produce energy for the neurons and regulate calcium levels, 
which are critical for the function and viability of the neurons. These intracellular 
organelles are dynamic and distribute throughout the neurons mediated by molecular 
motors that move along microtubule tracks. In axons, microtubules are polarized such that 
their plus ends are directed toward the axon terminals, in turn orienting the movement of 
distinct molecular motors in the antero- and retro- grade directions (Mandal et al., 2018). 
Intra-axonal movement direction also reflects mitochondrial fitness because stressed 
organelles are biased in the retrograde direction (Lin et al., 2017). Therefore, axonal 
mitochondria represent an optimal proxy for neuronal polarization, intracellular dynamics 
and overall cellular health. Two types of mitochondria, stable and motile ones, were present 
in sensory neurons. The stable mitochondria were large and dense than the motile ones 
which were small but highly dynamic (Figure 4.3A). From the kymographic analysis, I 
discriminated the static mitochondria which were represented by the vertical lines, the 
moving mitochondria with anterograde movement represented by the red lines and the 
mitochondria with retrograde movement represented by the green lines (Figure 4.3B). 
Quantification of the density of mitochondria in WT and Sarm1-/- did not show any 
statistical significance (Figure 4.3C). Moreover, neither the anterograde nor the retrograde 
speed of mitochondria was changed in Sarm1-/-, as compared to the WT siblings (Figure 
4.3D) (Tian et al., 2020). The percentage of stable and motile mitochondria was similar in 
WT and Sarm1-/-, in which stable mitochondria occupied approximately 88% of the total 
mitochondria in the sensory neurons (Figure 4.3E). Furthermore, I visualized the 
mitochondrial turnover with mitoTimer, in which the fluorescence shifts from green to red 
over time as the protein mature (Hernandez et al., 2013). To express the Timer into 
mitochondria, I cloned and injected the construct, SILL:mitoTimer. The images were 
captured by spinning disc microscopy on 5 dpf mitoTimer positive larvae. However, the 
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images did not show a difference of the mitochondrial turnover between the WT and 
Sarm1-/- (Figure 4.3F).  
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Figure 4.3 Loss of Sarm1 does not influence the number, movement and turnover of mitochondria 
of the sensory neurons.  A-B) Confocal image of axonal mitochondria marked with mito-mCherry in 
WT and Sarm1-/-. The mCherry signal was changed to grey here. The images were captured with 63x 
air objective. Red arrows point to prominent mitochondrial groups in axons. B) Upper panels, 
kymographs from videomicroscopic recording of axonal mitochondria in WT (A) (left panel) and 
Sarm1-/- (A) (right panel). The video was lasting for 150 seconds with 600 ms intervals. Lower panels 
show color-coded traces of moving mitochondria in anterograde (green) and retrograde (red) directions, 
taken from the kymographs shown in the upper panels. C) Quantification of the mitochondrial density 
in the axons in 5 dpf WT and Sarm1-/-, Error bar = SEM; Student’s t-test, n.s. = not significant, WT n = 
25, Sarm1-/- n = 19. D) Quantification of the mobility of mitochondria in the whole axons in 5 dpf WT 
and Sarm1-/-. Circles show the anterograde and triangles the retrograde movement of the mitochondria 
in the axons. p value from one-way ANOVA, WT n = 26, Sarm1-/- n = 26. E) Quantification of the stable 
and motile mitochondria in the axons in 5 dpf WT and Sarm1-/-. Rectangles with slash depict the stable 
mitochondria and the dash rectangles are the motile mitochondria. Error bar = SEM; Student’s t-test, 
n.s. = not significant, WT n = 26, Sarm1-/- n = 26. F) Confocal images show the expression of mitoTimer 
in the axons in 5dpf WT and Sarm1-/- larva. The red panels show the mature mitochondria and green 
panels the nascent mitochondria. Scar bar 20 μm (modified from Tian et al., 2020). 
4.4 Sarm1 is essential for the degradation of severed axons in zebrafish 
Loss of Sarm1 in Drosophila or in mice prevents the degradation of injured axons (Osterloh 
et al., 2012). To test functional conservation of Sarm1 in zebrafish, I used a previously 
established bioassay of nerve injury in the lateral-line system (Xiao and López-Schier, 
2016). The preparation employs intact larval zebrafish, laser-mediated severing of axons 
individualized by single-cell fluorescent-protein expression, and intravital high-resolution 
videomicroscopy of axons and their associated Schwann cells (Xiao et al., 2015a). 
Axotomy was done in fluorescently marked neurons by focusing an ultraviolet laser beam 
to a discrete region of the peripheral axons. Upon severing, the distal axonal segments 
quickly degenerated in WT, whereas the proximal segments remained associated with the 
intact neuronal perikaryon. This proximal part was normal and the regenerating axons 
would start to grow at 8 hpi (hours-post injury) (Figure 4.4.1A). However, the 
degeneration of distal segment axons was blocked in the severed specimens of Sarm1-/-. 
Kinetic analysis showed that WT axons degenerated through two phases: a fragmentation 
of the distal part that started as soon as 2 hpi, and a complete clearance that could complete 
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as early as 8 hpi (Figure 4.4.1B). By contrast, severed Sarm1-deficient axon segments 
retracked a very short distance and resisted degeneration more than 5 days (Figure 4.4.1C). 
However, the regrowth of proximal parts that starts from 8hpi, was normal in the WT and 
Sarm1-/- (Figure 4.4.1A-B). To confirm the altered axon degeneration is due to absence of 
Sarm1, I performed the rescue experiment by reconstituting the sarm1 protein in the Sarm1-
deficient larvae. SILL:mCherry construct was injected in the WT Tg[HGn39D]. The 
images showed that the axons labeled with GFP and mCherry undergo Wallerian 
degeneration after axon transection in WT. Next, I injected the SILL:mCherry or 
SILL:Sarm1-v2a-mCherry in the embryos from Tg[Sarm1-/-; HGn39D]. The images 
showed that the distal part of the transected axons degenerate in the Sarm1-v2a-mCherry 
positive axons which obtain the sarm1 expression but not in the mCherry ones (Figure 
4.4.1D). The published biochemistry work shows that Sarm1 executes the axon 
degeneration through dimerization of TIR domains after injury (Gerdts et al., 2015). Thus, 
I constructed the vectors with the truncated Sarm1 without TIR domain and expressed it in 
the Sarm1-/- larvae. The result shows that the TIR domain truncated Sarm1 could not rescue 
the phenotype of Sarm1 in axon degeneration (Figure 4.4.1E). Therefore, these data 
demonstrate that Sarm1 regulates Wallerian degeneration through its conserved TIR 
domain after transection in zebrafish (Tian et al., 2020).  
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Figure 4.4.1 Sarm1 is required for injury-induced peripheral axon degeneration in zebrafish. A-
B) Time-lapse images of axonal degeneration of GFP-labeled lateralis sensory neuron in WT (A) and 
Sarm1-/- larvae (B). hpi = hours post injury, scale bar 50 μm, white asterisk indicates the regrowing 
axons from the proximal stump. C) Quantification of the time from axon transection to fragmentation 
in WT n = 13 and Sarm1-/- n = 13. We observed the degeneration event up to 5 dpi maximum in our 
experiments. D) Confocal images of a severed lateralis nerve in the Tg[HGn39D] transgenic line (green) 
that also expresses mCherry in a fraction of axons in a WT (left) and a Sarm1-/- larva (center). The 
images on the right show a Sarm1-/- larva in which the red axons express a fusion between a functional 
Sarm1 and mCherry, revealing degradation of red axons and maintenance of green axons. Scale bar 100 
μm. E) Confocal images of the HGn39D (green) and constituted Sarm1 with TIR domain deletion (red) 
in Sarm1-/- larva. The images show that TIR domain is essential for Sarm1 conducting axon degeneration 
after transection. Scale bar 100 μm (modified from Tian et al., 2020). 
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Next, the central part axonal degeneration was visualized by injection of SILL:mCherry 
construct. The results were consistent with that of the peripheral axons which showed loss 
of Sarm1 impedes the degeneration of injured axons. Because of the central part with poor 
regenerative capacity (Xiao et al., 2015b), I did not observe the regenerative axons in WT 
and Sarm1-/- (Figure 4.4.2). These data suggest that Sarm1 influences the axon 
degeneration in both central and peripheral parts of the sensory neurons, but it does not 
affect the capacity of axon regeneration. 
 
Figure 4.4.2 Loss of Sarm1 blocks central axon degeneration after injury.  Time-lapse images of 
axonal degeneration of mCherry-labeled central part of lateralis sensory neuron in WT (up) and Sarm1-
/- larvae (down). The central part degraded quickly after transection in WT, not in Sarm1-/-. hpi = hours 
post injury, scale bar 50 μm. 
In C. elegans, severed axons can re-seal their proximal and distal stumps and restore the 
function quickly (Neumann et al., 2015). However, whether axons resealing occurs in other 
species remains unclear. I assessed this issue in Sarm1-deficient zebrafish, in which the 
distal part of transected peripheral axons does not degenerate and the proximal part retains 
regenerative capacity. To recognize the distal and proximal segments of the same axon 
after severing and during regrowth, I expressed individual lateralis neurons with Kaede, a 
photoconvertable protein that can be converted from Green into Red after exposing to 405 
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nm laser pulse (Ando et al., 2002). The positive larvae with Kaede_Green were transected 
with laser. 6 hours later (6 hpi), the distal parts of the axons were converted into 
Kaede_Red. Then, the larvae were released into the incubator. All the images were taken 
at 14 hpi with confocal microscopy (Figure 4.4.3A). The representative images showed 
that the distal axons with Kaede_Red did not reseal with the Kaede_Green labeled 
regenerative axons (Figure 4.4.3B). The high magnification image was the rectangular 
dash box from Figure 4.4.3B, showing clear detail of the action of these two axonal 
segments. The regrowing axon did not reseal with the non- degradable distal part. However, 
the regrowing proximal axon grew bypath the old non-degradable segments and re-
innervated neuromasts (Figure 4.4.3C). This experiment was reproducible in more than 
twenty individual larvae. I did not observe the resealing event in the regeneration of sensory 
neurons. These results indicate that the resealing of transected axons does not occur in 
Sarm1- deficient zebrafish. The vertebrate might lose the capacity to reseal injured axons. 
 
Figure 4.4.3 Regenerating axons do not reseal with non-degradable segments in zebrafish. A) 
Schematic representation of the experimental strategy to test the axon resealing in Sarm1-/- transected 
axons expressing Kaede. Photoconversion of distal segment was performed 6 hours post injury (hpi), 
and imaging 14 hours afterwards. B) Confocal images of the photoconversion experiment. Kaede_G is 
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the green (native) form of Kaede, in the proximal (regrowing) axon; Kaede_R is the red 
(photoconverted) form of Kaede in the non-degradable (distal) axon segment. Scale bar 40 μm. The 
dotted box indicates the site of transection, which also contains the juxtaposition between the proximal 
end of the distal axon segment and the passing regenerated axon. Note the arborization of the green axon 
below a neuromast. C) Zoomed from the dotted box in (B), detailing the interphase between the non-
degradable distal axon (orange) and the passing regenerated proximal axons (green) (modified from 
Tian et al., 2018).  
4.5 Synthetic elevation of intracellular calcium suffices to induce the 
degradation of severed Sarm1-deficient axons 
Calcium regulation is critical for neuronal homeostasis because sustained elevation of 
cytosolic calcium leads to axonal degeneration. This occurs because mitochondria release 
apoptosis-inducing factors and proteases in a calcium-dependent manner (Ozaki et al., 
2009). In addition, calcium influx is essential for axonal microtubule breakdown via 
calpain activity which cleaves the microtubules and induces the axon fragmentation (Ma 
et al., 2013; Yang et al., 2013). To understand the role of Sarm1 in calcium influx, I 
monitored the calcium influx in axoplasm, mitochondria, and endoplasmic reticulum when 
the axons were severed. To visualize the calcium influx in axoplasm, SILL:Gal4 and 
UAS:mCherry constructs were co-injected into embryos from the Tg[UAS:GCaMP7a; 
Sarm1-/-] or Tg[UAS:GCaMP7a; WT] transgenic lines. The calcium signal was captured 
by spinning disk microscopy with 2.5 Hz (400 ms per frame). Undamaged wild-type and 
Sarm1-deficient axons showed undetectable levels of axoplasmic fluorescence above 
background. Upon severing, the fluorescent signal in WT axons distal segments increased 
immediately and subsequently decayed with a near constant slope, whereas fluorescence 
remained undetectable in Sarm1-deficient distal axon segments (Figure 4.5.1A). The 
quantification of calcium signals showed that the ΔF/F0 reached 1.4 in WT after 
transection, indicating that the calcium signal was increased 1.4-fold of the basal level; 
however, in Sarm1-/-, the ΔF/F0 was 0.15 after transection. The statistical analysis showed 
the difference between WT and Sarm1-/- (Figure 4.5.1B). These results show that Sarm1 
deletion prevents the calcium influx into the axoplasm in injury.  
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To monitor the calcium signal in mitochondria, the mitochondrial located RGECO (red 
calcium channel sensor) (Esterberg et al., 2014), was expressed in the sensory neurons with 
the construct, SILL:mitoRGECO. The images showed that the RGECO labelled 
mitochondria are red dots or tubulars along the axons. Upon severing, the signal of RGECO 
was enhanced in both WT and Sarm1-/- samples (Figure 4.5.1C). The quantification result 
showed that the calcium signal was elevated around 0.2-fold after axon transection. 
However, there was no statistical significance between WT and Sarm1-/- (Figure 4.5.1D).  
In addition, the calcium activity in ER was examined with the sensor, ER-GCaMP3, which 
includes the ER target sequence in the N terminal of the GCaMP3. The basal level of 
calcium signal was stronger in ER than in cytosol, because GCaMP3 is more sensitive than 
GCaMP7a (Muto et al., 2013). Upon injury, the calcium signal of ER was increased in both 
groups, WT and Sarm1-/-, but without statistical significance (Figure 4.5.1E-F). Taken 
together, these results demonstrate that loss of Sarm1 attenuates the calcium influx into the 
axoplasm but not Ca2+ uptake in mitochondria and endoplasmic reticulum (Tian et al., 
2020).  
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Figure 4.5.1 Loss of Sarm1 attenuates axoplasmic calcium influx but not mitochondrial and ER 
calcium uptake in injury. A) Confocal image of a single lateralis sensory axon expressing the green-
fluorescent calcium sensor GCaMP7a in WT (left column) and Sarm1-/- fish (right column). Rows show 
the same samples before laser-mediated transection (top), immediately after transection (middle) and 
60 seconds after transection (bottom). Scale bar 20 μm. B) Shows quantification of the first wave of 
axoplasmic calcium. Data are shown as mean ± SEM; p from one-way ANOVA, WT n = 16, Sarm1-/- n 
= 16. C) Shows a confocal image of lateralis sensory axons expressing the red-fluorescent calcium 
sensor RGECO in WT (left column) and Sarm1-/- zebrafish (right column). Rows show that same 
samples before laser-mediated transection (top), immediately after transection (middle), and 60 seconds 
after transection (bottom). D) Quantification mitochondrial calcium influx shows the strong and nearly 
identical elevation and decay in WT and Sarm1-/- immediately after the cuts. The data is shown as mean 
± SEM; p from one-way ANOVA, WT n = 16, Sarm1-/- n = 16.  E) Shows a confocal image of lateralis 
sensory axons expressing the green-fluorescent calcium sensor CCaMP3a targeted to the endoplasmic 
reticulum (ER) in WT (left column) and Sarm1-/- fish (right column). Rows show that same samples 
before laser-mediated transection (top), immediately after transection (middle), and 60 seconds after 
transection (bottom). F) Quantification ER calcium influx shows strong and statistical equal elevation 
and decay in WT and Sarm1-/- after transection. Data are shown as mean ± SEM; p from one-way 
ANOVA, WT n = 16, Sarm1-/- n = 16 (modified from Tian et al., 2020).   
Studies in mammalian and zebrafish have shown that neuronal damage triggers two waves 
of elevation of axoplasmic calcium (Ca2+), and the second wave of calcium activates the 
Wallerian degeneration through Calpain which facilitates axonal fragmentation by cleaving 
microtubules and neurofilaments (Park et al., 2013a; Vargas et al., 2015). To observe the 
calcium changes in the distal segments, I performed live imaging of the transected axons 
with spinning disc microscopy for 12 hours. The images showed that the second wave of 
calcium influx occurs at 4 hpi in WT, when the axon has not degenerated yet. 2 hours later, 
the axon was under fragmentation and the calcium signal was weakened sequentially. By 
contrast, the second wave of axoplasmic calcium signal did not come up in Sarm1- 
deficient axons up to 12 hpi (Figure 4.5.2A-B).   
Moreover, I monitored the calcium signal in mitochondria in the late stage of axonal 
degeneration. The images showed that the mitochondrial calcium was enhanced at 3 hpi in 
WT, which is around the same time as the axoplasmic calcium influx; however, the 
mitochondrial calcium concentration was not changed in the Sarm1-/-. It shows that the 
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axoplasmic calcium influx from the extracellular space increases the mitochondrial 
calcium uptake before axon fragmentation. It has been reported that the influx calcium is 
the source of mitochondrial calcium in axon degeneration (Villegas et al., 2014). At later 
time, the RGECO labelled axons underwent fragmentation, but there was no obvious 
difference of the calcium signal before and after axon fragmentation in WT. In contrast, 
although the distal segments were not fragmented in Sarm1-/-, the mitochondrial calcium 
was not changed (Figure 4.5.2C). Taken together, absence of Sarm1 impairs the 
axoplasmic calcium influx which is essential for axonal fragmentation in early and later 
stages of axonal degeneration after axotomy (Tian et al., 2020).  
 
RESULTS 
73 
Figure 4.5.2 Second wave of axoplasmic calcium influx triggers axon fragmentation. A) Confocal 
images of lateralis sensory axons expressing the mCherry (red) and green-fluorescent calcium sensor 
GCaMP7a (green) in WT zebrafish. Rows show same axons 2, 4, 8 and 12 hours after transection (hours-
post-injury = hpi). B) Confocal image of lateralis sensory axons expressing the mCherry (red) and green-
fluorescent calcium sensor GCaMP7a (green) in Sarm1-/- zebrafish. Scale bar 20 μm. C) The 
mitoRGECO was fragmented and become clustered in the WT, but the strength of the calcium signal 
was not changing. However, the mitoRGECO did not change in the Sarm1-/-. Scale bar 20 μm (modified 
from Tian et al., 2020). 
Further, I used the capsaicin/ratTRPV1 (transient receptor potential cation channel 
subfamily V member 1) system to enforce the axoplasmic calcium influx in Sarm1-
deficient axons. The TRPV1 in rat is sensitive to capsaicin, whereas the orthologue TRPV1 
in zebrafish is not. Thus, ratTRPV1 has been used to manipulate the calcium activity in 
zebrafish (Chen et al., 2016; Gau et al., 2013). First, I expressed the ratTRPV1-tgRFP in 
the GCaMP7a transgenic axons in Sarm1-/-. Then, I monitored the calcium signal with or 
without capsaicin incubation. The results showed that the calcium signal was obviously 
enhanced in the ratTRPV1 positive neurons in presence of the capsaicin (Figure 4.5.3A). 
Calcium influx is induced by ratTRPV1/capsaicin in the Sarm1-deficient axons, indicating 
that the calcium activity is downstream of Sarm1 in axon degeneration. Next, I injected the 
construct SILL: ratTRPV1-tgRFP or SILL: mCherry in the embryos of Tg[Sarm1-/-; 
HGn39D] respectively. The positive larvae were the ones with both green fluorescence 
labeling of all the sensory neurons and red fluorescence labeling of the ratTRPV1-
expressing neurons. Then, I transected all the axons and incubated the larvae in vehicle 
(ethanol) or capsaicin. Finally, the images were taken at 1.5h later by confocal microscopy 
(Figure 4.5.3B). The results show that capsaicin does not affect the transected axons in 
Sarm1-/-, because the HGn39D and SILL:mCherry labelled transected axons did not 
fragment in presence of capsaicin (Figure 4.5.3C). However, ratTRPV1 positive Sarm1-
deficient neurons rapidly degraded in the presence of capsaicin. Neither the HGn39D 
positive ones nor the ratTRPV1 positive neurons degraded with control (ethanol) 
incubation (Figure 4.5.3D-E). Thus, these results confirm that the calcium signal is 
downstream of Sarm1 for axon degeneration. Elevation of axoplasmic Ca2+ is sufficient to 
trigger the degradation of Sarm1-deficient axons in vivo (Tian et al., 2020).   
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Figure 4.5.3 Synthesis elevated axoplasmic calcium influx induces axon fragmentation in Sarm1-
/- zebrafish. A) Confocal images of the GCaMP7a (Green) and TRPV1-tgRFP (red) before and after 
capsaicin treatment in Sarm1-/- zebrafish, which shows the calcium influx under capsaicin treatment. 
Scale bar 20 μm. B) Schematic representation of the experimental strategy to synthetically elevate 
calcium in transected Sarm1-/- axons. Lateralis sensory neurons expressed a transgene coding for the rat 
transient receptor potential cation channel subfamily V member 1 (ratTRPV1) fused to tgRFP, or 
mCherry as a control. Two hours after axon transection, zebrafish larvae were bathed in ethanol solution 
(control), or ethanol containing capsaicin, a natural activator of TRPV1. 90 minutes after treatments, 
larvae were imaged by confocal microscopy to assess the extent of distal segment degradation. C) 
Sarm1-/- zebrafish expressing GFP in all lateralis neurons (Tg[HGn39D]) and mCherry in a mosaic 
manner in some neurons. The sample was treated with 10um capsaicin. Scale bars 100 μm.  D) Sarm1-
/- zebrafish expressing GFP in all lateralis neurons and ratTRPV1-tgRFP in a mosaic manner. The 
sample was incubated in ethanol solution 1/1000 (vol/vol). Scale bars 100 μm. E) Sarm1-/- zebrafish 
expressing GFP in all lateralis neurons and ratTRPV1-tgRFP in a mosaic manner. Capsaicin treatment 
induced transected axon degradation (former location of the axon signaled by three white arrows). Scale 
bars 100 μm (modified from Tian et al., 2020). 
4.6 Equivalent sensorimotor recovery after nerve regeneration in wild 
type and Sarm1-deficient zebrafish 
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To know what happens when the regenerating axons get into the neuromast, I generated 
the transgenic line, Tg[Sarm1-/-; SILL:mCherry; Brn3c:Gal4; UAS:GCaMP7a]. After 
axon transection, I took the time-lapse imaging of the neuromasts, which were innervated 
by the sensory axons. Compared to the non-degradable transected trunks, the axonal 
branches in neuromasts were divided into two groups, degradable and non-degradable 
branches. In the degradable ones, the regenerating axons got into the neuromast and 
innervated the related hair cells around 14 hpi. This was consistent to the WT, in which the 
old axons degenerated and were eradicated, releasing the space and touching sites for the 
innervation of regenerative axons and neuromast. In the non-degradable ones, the old axons 
were maintained in surrounding of the neuromast. But, the terminal of non-degradable 
axons became small dots and detached from the neuromast, releasing the connected sites 
to the regenerative axons. Moreover, the non-degradable segments did not repel the 
regenerative axons to innervate hair cells (Figure 4.6.1A-B). These results show that 
regenerative sensory axons could innervate the neuromasts normally in Sarm1-deficient 
zebrafish. 
 
Figure 4.6.1 Regrowth of axons innervate neuromasts in Sarm1-/- zebrafish after axon transection. 
A) Confocal images of the regrowing axons towards to the neuromast in Sarm1-/-. Time points are 
indicated in the upper- left of the images. Asterisks indicate the pigment. Arrows show the regrowth site 
RESULTS 
76 
of new axons towards to neuromast after transection. Scale bar 20 μm. B) Confocal images of the 
regrowth axons towards to the neuromast in Sarm1-/-. Time series are in the down left of the images. 
Asterisks indicate the pigment. Arrowheads show the regrowth site of new axons towards to neuromast 
after transection. Scale bar 20 μm.  
To test the impact of systemic loss of Wallerian axon degeneration on sensorimotor 
recovery after damage, I employed the natural regeneration of the lateralis peripheral nerve. 
It has been reported that unilateral abrogation of anterior and posterior lateral-line 
decreases the orienting performance of fish in laminar flow (Oteiza et al., 2017). I 
performed and quantified the rheotaxis tests on following experimental groups: WT, 
Sarm1-/-, WT 1 dpi, Sarm1 1 dpi, WT 3 dpi, and Sarm1-/- 3 dpi. The dpi (days post injury) 
groups had been transected on one-side either at the level of the anterior or posterior lateral-
line. Therefore, they had lost all the connection between sensory organs and the central 
nervous system. The performance of the intact larvae shows no statistical difference 
between WT and Sarm1-/-. The distribution of quantified performance was in a small range, 
which varied from 0.8-1 (Figure 4.6.2). 
In the lateral-line transected groups, the orientation performance of larvae was affected 
dramatically. From the quantification results, cosines of orientation were distributed from 
0.1-0.95 in the WT 1 dpi group and Sarm1-/- 1 dpi group. There was statistical significance 
between intact and 1 hpi groups in either WT or Sarm1-/- individually. But in the 
orientation, there was no statistical significance between WT 1 dpi and Sarm1-/- 1 dpi 
groups. It indicated that the non-degradable axons do not improve the performance of 
orientation in Sarm1-/- zebrafish. In addition, the range of cosine of orientation increased 
to 0.3-1 in WT 3 dpi and Sarm1-/- 3 dpi groups. Comparing to the 1dpi groups, it 
demonstrates that the performance of rheotaxis is improved after three days recovery from 
injury in both WT and Sarm1-/-. However, there was no statistical significance between WT 
3 dpi and Sarm1-/- 3 dpi (Figure 4.6.2). Considering the regenerated axons are compatible 
to the non-degradable severed ones in the Sarm1-/- 3 dpi, the results suggested that the non-
degradable axons in Sarm1-/- do not retard the functional recovery of injured nerves. Taken 
together, these results show that non-degradable axon does not improve or suppress the 
performance of orientation in Sarm1-/-. In other words, the maintenance of severed axons 
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in Sarm1-/- zebrafish does not affect the re-innervation of sensory receptors with 
regenerative axons, or restoration of sensory function after circuit repair. 
 
Figure 4.6.2 Equivalent sensorimotor recovery after nerve regeneration in wild type and Sarm1-/- 
zebrafish. Rheotaxis of 7 dpf larva in the indicated groups. Sham: sham ablation of the lateralis nerves. 
1 dpi: 1 day post injury; 3 dpi: 3 days post injury. p values were from the Wilcoxon rank sum test. n = 
7 for each group, 10 trails for each larva (modified from Tian et al., 2018). 
4.7 Schwann cells do not change the phenotypes after axon severing in 
Sarm1-deficient zebrafish 
Schwann cells support, fasciculate and myelinate sensory axons in vertebrates. They also 
present phagocytic activity to eliminate damaged axons (Lutz and Barres, 2014). To assess 
the morphology of Schwann cells and the interaction between Schwann cells and axons, I 
generated the Tg[SILL:mCherry; gSAGFF202A; UAS:GFP] line. The confocal images 
showed that the green fluorescence labelled Schwann cells ensheathed and distributed 
along the red fluorescence lateralis afferent neurons. There was no obvious difference in 
WT and Sarm1-/- zebrafish larvae (Figure 4.7.1A). Next, I tested the calcium activity of 
the Schwann cells of 4 dpf larvae upon injury. In the Tg[Sarm1-/-; gSAGFF202A; 
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UAS:GCaMP7a] larva, calcium influx was triggered normally during transection, 
comparing to the WT (Figure 4.7.1B). Therefore, these data suggest that Schwann cells 
develop and fasciculate sensory axons normally in Sarm1-deficient zebrafish. 
 
Figure 4.7.1 Loss of Sarm1 does not influence the morphology and calcium influx of Schwann cells 
in lateral line. A) Confocal images of a double transgenic 5 dpf larva showing Schwann cells marked 
by expression of GFP (green) under the control of the Tg[gSAGFF202A] Gal4 driver, and lateralis 
afferent neurons marked by expression of mCherry under the control of the SILL enhancer (red). WT 
(top), Sarm1-/- (bottom). Scale bar 20 m. B) Confocal images show the calcium signal in Schwann cells 
before and after transection in WT and Sarm1-/-. The GCaMP7a labeled Schwann cells were controlled 
by the gSAGFF202A-Gal4 driver with UAS-GCaMP7a, Scale bar 20 m (modified from Tian et al., 
2020).  
Upon severing, fragmented axons are quickly cleared by the Schwann cells. With the high-
resolution intravital microscopy, I observed that the fragmented axons were engulfed and 
were degraded by Schwann cells in WT (Figure 4.7.2A). However, the engulfment and 
clearance events did not occur in Sarm1-/-, because no axonal fragmentation occurred 
(Figure 4.7.2B).  
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Figure 4.7.2 Schwann cells involve in axon debris clearance. A, B) Images show the indicated time 
points after axon transection (hours post injury = hpi) from a videomicroscopic recording of Schwann 
cells (green) and their interaction with axons (red) in WT and Sarm1-/-. White arrowheads indicate 
Schwann cells engulfing axonal debris in the WT. A white arrow indicates degradation-resistant axon 
segment in Sarm1-/-. Please note that the proximal axon stumps in are not visible in these images because 
they are outside the focal plane (modified from Tian et al., 2020). 
When an injury generates a gap in the glia, wounded-adjacent Schwann cells actively move 
and extend cellular processes resembling filopodia to reconstitute a continuous glial 
scaffold rapidly. Although continuous glia is not necessary for the regrowth of proximal 
axon stump, it prevents regenerating growth cones from straying, in turn facilitating end-
organ de novo innervation and circuit reconstitution (Rosenberg et al., 2014; Xiao et al., 
2015a). Thus, I decided to assess Schwann-cell behavior immediately after axon severing 
and during axon regeneration by combining Tg[gSAGFF202A;UAS-GFP; SILL:mCherry] 
double transgenic lines with Sarm1-/-. As expected, I found that Schwann cells adjacent to 
the wound quickly extended filopodia to close the gap in the glial scaffold ahead of axonal 
regeneration in WT animals. The re-growing axons then followed these sub-cellular glial 
bridges to reconstitute the nerve, suffering mild de-fasciculation restricted to a small area 
within the injury (Figure 4.7.3A and Figure 4.7.4). In contrast, injury-adjacent Schwann 
cells did not migrate or produce filopodia-like projections ahead of axonal regeneration in 
Sarm1-/-. Nonetheless, regenerating axons eventually negotiated the persistent larger gap 
to grow along the distal glial scaffold. However, the reforming nerves presented more 
pronounced local de-fasciculation, and the Schwann cells finally filled up the gaps in 
Sarm1-/- (Figure 4.7.3B and Figure 4.7.5). This result indicates that the filopodia-bridge 
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from Schwann cells is not essential for the regrowth of axons in Sarm1-/- zebrafish (Tian et 
al., 2020). 
 
Figure 4.7.3 Filopodia-bridge from Schwann cells is not essential for the regrowth of axons in 
Sarm1-/- zebrafish. A) Images show the discrete local defasciculation of regenerated sensory fiber (red) 
and the bridging of the glial gap by Schwann cells (green) in a WT specimen. B) Equivalent experiment, 
images showing a more pronounced local defasciculation of the regenerated sensory fiber (red) in a 
Sarm1-/- specimen. Note that the bridging of the glial gap does not occur (modified from Tian et al., 
2020). 
 
Figure 4.7.4 Series of images enlarged from Figure 4.7.3A. They show eight time points during the 
repair of the gap in the Schwann cell scaffold (A-H) and axonal regeneration after transection (A’-H’) 
in a WT animal. Rostral is left and caudal is right. In all panels, the green asterisks show the location of 
the pioneering growth cone of the regenerating axons. In A-D’ the purple arrowheads mark the 
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filopodia-like extensions from Schwann cells adjacent to the glial gap. At the start of the series, (A, A’) 
the axonal terminal stump and the Schwann cells proximal to the gap co-localize (near juxtaposition of 
the green asterisk and the purple arrowhead. In B, a Schwann cell extends a filopodium across the gap, 
whereas the axons (B’) do not grow along this extension across the gap. In C, several extensions from 
Schwann cells are clearly visible at the top and bottom aspects of the image. The shape of the lower 
extension from a Schwann cell did not change, suggesting that they are stabilized, perhaps through 
interactions with the substrate. Proximal axons (C’) start to grow along these Schwann-cell protrusions. 
In D, the extensions from the anterior and posterior Schwann cells have crossed the gap, physically 
interact and commence to reconstitute a continuous glial scaffold. The axonal projections (D’), however, 
have suffered a retraction towards the proximal stump. E-F show a continuation of Schwann cells 
behavior, increasing the contacts and closing the gap, which is obvious by the smaller area of the gap 
(distance between proximal and distal Schwann cells). E’-F’ show a more robust and persistent 
extension of the axonal growth cones, which grow nearly strictly along the Schwann cells extensions. 
G-H show the Schwann cells closing the gap. G’-H’ show axonal extension across the gap and along 
the distal Schwann cells. Although the gap in the glial scaffold is much reduced, nerve fibers show 
discrete defasciculation (H’) (modified from Tian et al., 2020).  
 
Figure 4.7.5 Series of images enlarged from Figure 4.7.3B. They show six time points during the 
repair of the gap in the Schwann cell scaffold (A-F) and axonal regeneration after transection (A’-F’) in 
a Sarm1-/- specimen. In all panels, the green asterisks show the location of the pioneering growth cone 
of the regenerating axons, and the purple arrowheads mark filopodia-like extensions from Schwann 
cells. Unlike the wild-type situation, the Schwann cells adjacent to the gap form small filopodia-like 
extensions (B-D) that never cross the gap. The proximal stump eventually forms growth cones that cross 
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the gap at various locations (C’) and, upon finding distal Schwann cells, grow along the glial scaffold 
(D’-F’). Nerve fibers show extensive local defasciculation (F’) (modified from Tian et al., 2020).  
After injury, the denervated Schwann cells are changing the state from myelinating to a 
progenitor-like by partial dedifferentiation rapidly. This is confirmed by checking the 
expression of terminal-phenotype markers, including myelin and myelin related proteins 
(Sasaki et al., 2018; Soto and Monje, 2017). In addition, the progenitor state Schwann cells 
is able to proliferate and migrate along the axons, which enhances their regenerative 
function (Carr and Johnston, 2017). I hypothesized that the distal Schwann cells may not 
dedifferentiate and retain the terminal phenotype, because the non-degradable axons 
maintain the Schwann cells in Sarm1-/-. This would explain why Sarm1-deficient SCs loss 
phagocytic and protrusive activities after axon transection. Following this hypothesis, I 
performed the immunostaining of transected samples with an antibody against Claudin-k, 
which localizes the junctions between mature Schwann cells and was downregulated in 
denervated glia (Xiao et al., 2015a). In WT specimens, Claudin-k maintained strong 
expression along the entire lateralis afferent nerves up to 6 hours post injury (hpi), 
suggesting that the distal Schwann cells remain mature during distal axon fragmentation. 
After 10 hpi, the injured axons degenerated and the Schwann cells in the distal part had 
remarkably less Claudin-k than proximal ones. Finally, the Claudin-k was conspicuously 
absent from the distal Schwann cells even after axons regeneration had commenced 
(Figure 4.7.6B). By contrast, Claudin-k remained strongly expressed after axon severing 
in Sarm1-/- larva from 6 hpi to 24 hpi, with no obvious difference between Schwann cells 
located at both sides of the transected site (Figure 4.7.6C). Next, I assessed myelination of 
axons with the 6D2 monoclonal antibody, which recognizes a carbohydrate epitope in the 
piscine p0-like myelin glycoproteins IP1 and IP2 (López-Schier and Hudspeth, 2005). In 
the WT specimens, the immunostaining of 6D2 did not change up to 10 hpi. Compared to 
Claudin-k, the 6D2 was degraded much slower in the distal part after injury (Figure 
4.7.6D). It disappeared around 24 hpi in WT. However, the expression of 6D2 was retained 
in Sarm1-deficient samples after injury (Figure 4.7.6E). Taken together, these results 
reveal that Schwann cells distal to the injury do not de-differentiate in Sarm1-/- specimens 
(Tian et al., 2020). 
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Figure 4.7.6 Non-degradable Sarm1-deficient axons maintain the tight junction and myelin of the 
distal segments. A-C) Schematic model of the confocal imaging locations on severed axons (A). 
Confocal images of WT (B) and Sarm1-/- (C) specimens in 6 hpi, 10 hpi and 24 hpi. hpi = hour post 
injury. The specimens were the Tg[gSAGFF202A;UAS:EGFP; SILL:mCherry] lines and were stained 
with Claudin-k (magenta) antibody. Scale bar 50m.  D-E) Confocal images of WT (D) and Sarm1-/- 
(E) specimens expressing EGFP in sensory neurons of the lateral line (green) and stained with the 
monoclonal antibody 6D2. Immunostainings were performed at indicated time points after axon 
severing (hpi). The arrows point to the cutting sites. Scale bar 50 m (modified from Tian et al., 2020). 
Next, I used live imaging to investigate the dynamics of axons and associated myelin after 
injury in 4 dpf larvae from WT or Sarm1-/-. The myelin was labelled by expressing 
membrane-targeted EGFP fused to the myelin binding protein. In the WT larvae, the 
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degradation of myelin happened later than the fragmentation of severed axons. Around 8 
hpi, the severed axons were undergoing fragmentation and degradation, but the 
morphology of myelin was normal. From 12 hpi, most axonal debris had already been 
cleared. Meanwhile, the myelin was collapsing and fragmenting. Until 16 hpi, the 
regenerative axons grew normally, while the myelin was still present (Figure 4.7.7A). In 
contrast, the myelin did not change after severing axons in the Sarm1-/- samples. Moreover, 
the regrowing axons were not affected by the non-degradable axons and myelin (Figure 
4.7.7B). These results suggest that the degradation of myelin is a consequence of axon 
fragmentation after injury. Sarm1-deficient neurons keep the distal axons and their 
associated myelin intact after axotomy, and the clearance of myelin is not necessary for 
axon regrowth (Tian et al., 2020).  
 
Figure 4.7.7 Clearance of axonal and myelin debris is not essential for axon regeneration. A) Live 
imaging of the Tg[Mbp-EGFP; SILL:mCherry] after severing. The arrows indicated the fragmented 
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axons and the arrowheads the fragmented myelin. Scale bar 20 m. B) Live imaging of the Sarm1-/- in 
Tg[Mbp-EGFP; SILL:mCherry] after severing. Arrows indicate regrowing axons, and arrowheads 
indicate the juxtaposition between the regrowing axons. Scale bar 20 m (modified from Tian et al., 
2020). 
4.8 Schwann cells are not essential for the maintenance of Sarm1-
deficient axonal segments 
To know whether Schwann cells are necessary for the maintenance of severed Sarm1-
deficient axons, I generated a double knockout zebrafish line concurrently deficient in 
Sarm1 and Erbb2, the latter being required for Schwann cells migration along the axons 
(Lyons et al., 2005). Loss of Erbb2 leads to the lateralis nerve defasciculation in zebrafish 
(Lyons et al., 2005; Xiao et al., 2015a). In the Erbb2-deficient specimens, the distal portion 
of severed axons fragmented and were cleared, but with a significant delay of 
fragmentation time, as compared to WT specimens (Figure 4.8.1A). In WT, the average 
fragmentation time was around 4 hours after axon severed, but it delayed to 12 hours in the 
Erbb2-/-. By contrast, in Sarm1-/-Erbb2-/-, severed axons did not fragment or degrade, as 
well as the fish lacking only Sarm1 (Figure 4.8.1B). Similar to the Erbb2-/-, the 
regeneration of axons was not affected in the double knockouts line. At a later time, the 
axonal debris was cleared in both Erbb2-/- and Sarm1-/-Erbb2-/- specimens, indicating that 
the clearance of axon debris was not fully dependent on Schwann cells (Figure 4.8.1A). 
Taken together, maintenance of severed axon in Sarm1-/- occurs independently of Schwann 
cells, and the Schwann cells are partially involved in axon debris clearance (Tian et al., 
2020). 
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Figure 4.8.1 Schwann cells are not essential for the maintenance of Sarm1-deficient axonal 
segments. A) Images of mCherry-expressing (red) transected axons in Erbb2-/- and Sarm1-/-; Erbb2-/- 
double knockouts. Scale bar 100 m. B) Quantification of transected axon fragmentation in Erbb2-/- and 
Sarm1-/-; Erbb2-/-. Error bar = SEM, p value from one-way ANOVA, n = 15 (each group) (modified 
from Tian et al., 2020). 
Next, I expressed the ratTRPV1-tgRFP and EGFP into the Tg[Erbb2-/-; Sarm1-/-] larvae to 
label the axons with GFP alone or both GFP and ratTRPV1-tgRFP. The posterior lateral 
nerve of 4 dpf positive larvae were severed with laser. One hour later, the larvae were 
incubated with capsaicin for one hour. The images were taken with confocal microscopy 
10 hours later. As shown in the representative images, the ratTRPV1-tgRFP and GFP 
positive axon was degraded in presence of capsaicin (the arrow indicating one), although 
the axons lacked Schwann cells. In contrast, the axon without ratTRPV1-tgRFP was not 
degraded (the arrowhead indicating GFP-positive one) (Figure 4.8.2). These results 
suggest that the axoplasmic calcium influx which induces the axon fragmentation was not 
completely dependent on Schwann cells. Moreover, Schwann cells are not essential for the 
maintenance of severed Sarm1-deficient axonal segments. 
 
Figure 4.8.2 Schwann cells are dispensable for the clearance of Sarm1-deficient axonal debris.   
Confocal images of the GFP labeled axons (SILL:Gal4; UAS-EGFP) with or without Trpv1 positive 
axons (SILL:Gal4; UAS:ratTRPV1-tgRFP) in Erbb2-/- and Sarm1-/- double knockouts before and after 
capsaicin incubation. Arrowheads indicate the GFP labelled axons. Arrows indicate the GFP and 
ratTRPV1 double expressed axon. Scale bar 50 μm. 
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4.9 Loss of Sarm1 slightly delays the remyelination of regenerative axons. 
Axons are wrapped by myelin which isolates the axons from the outside environment, 
enhances the action potential conduction, and maintains the nerve fasciculation (Raphael 
and Talbot, 2011). To assess the myelination of axons, I generated the Tg[HGn39D; mbp-
tgRFP] lines in a WT or Sarm1-/- background. I observed that the myelin ensheathed axons 
of posterior sensory neurons of WT and Sarm1-deficient zebrafish larvae. However, the 
morphology and density of the myelin did not show any obvious difference between WT 
and Sarm1-/- (Figure 4.9.1A-B). These images suggest that Sarm1 deficiency does not 
influence the myelination of axons in the development of posterior lateral line nerves. 
 
Figure 4.9.1 Overview of the myelination in wild type and Sarm1-/- zebrafish. A) Confocal images 
of whole view of axons and myelin in WT (top) and Sarm1-/- (down). The samples were the 
RESULTS 
88 
Tg[HGn39D; mbp-tgRFP] lines. Scale bar 400 m. B) High magnification images of the axons and 
myelin in WT and Sarm1-/-. Axons were green (HGn39D) and myelin (Mbp-tgRFP) was red. Scale bar 
50 m. 
The peripheral neurons can recover functionally from injury, in which the regenerative 
axons are myelinated by Schwann cells (Ceci et al., 2014). I continued the live imaging to 
track the remyelination capacity of Schwann cells after severing axons in WT and Sarm1-
/- zebrafish larvae. The dynamic of new myelin formation was displayed with a montage of 
time-lapse images. I found that the myelination was starting earlier than 48 hpi and the 
myelin was much thicker in the WT than in the Sarm1-/-. In addition, the myelination of 
regenerated axons was completed quickly in the WT animals. By contrast, in the Sarm1-/- 
ones, the myelination of regenerated axons was a bit slower, indicating that the myelination 
capacity of the Schwann cells was not disrupted in the Sarm1-/- (Figure 4.9.2A-B). These 
results suggest that loss of Sarm1 only marginally affects the myelination of regenerated 
axons. 
 
Figure 4.9.2 Remyelination is slightly slower in Sarm1-/- zebrafish. A) Montage images showing a 
time lapse imaging of Tg[mbp:tgRFP] after axotomy. The red arrows indicate the process of 
remyelination in WT. B) Montage images displaying the time lapse imaging of the Sarm1-/- in 
Tg[mbp:tgRFP] after axotomy. The red arrowheads indicate the progress of remyelination in Sarm1-/-.  
RESULTS 
89 
4.10 The recruitment of macrophages is not impaired in Sarm1-deficient 
zebrafish 
Macrophages are recruited into the injured axons for clearing the axon debris (Bendszus 
and Stoll, 2003). Sarm1 has an essential role in CCL5 induction in macrophages (Gürtler 
et al., 2014). I wondered whether macrophages lose the capacity to move into the injured 
axons and eradicate the axon debris for regeneration in Sarm1-/- zebrafish larvae. In order 
to observe the recruitment of macrophages, I generated the transgenic line, Tg[mfap4: 
EGFP-CAAX], which allows live, long-term analysis of macrophage behavior (Walton et 
al., 2015). The time-lapse images started from 30 mins after severing the axons of posterior 
sensory nerves. The panels scope the images from 3 hours post injury to 14 hours post 
injury. In the WT larva, the macrophages were recruited to the distal segments of axons 
and cleared the fragmented axons. In the stage of axonal regeneration, the macrophages 
still stayed in surrounding of the regenerating axons. In the Sarm1-/-, the macrophages were 
recruited to and moved along with the transected axons. The movement of the macrophages 
suggested that they were screening and surveilled the intact of the axons. Even in the Erbb2-
/-, which lack of Schwann cells, the macrophages moved to the injury axons for cleaning 
the debris (Figure 4.10A). Next, I found that the onset of recruitment and number of 
macrophages at the wound did not differ between WT and Sarm1 or Erbb2 knockout 
(Figure 4.10B). The retention time of macrophages at the proximal side of the wound was 
unaltered in Sarm1-/- or Erbb2-/-, although on average slightly lengthened in the absence of 
Schwann cells (Figure 4.10C). However, I found a significant increase in the size of the 
engulfed debris by macrophages in Erbb2-/- animals (Figure 4.10D). When I fragmented 
axons with ratTRPV1/Capsaicin in WT or Sarm1-/-, I found macrophages were still 
recruited to the axon debris (Figure 4.10E). These results reveal that loss of Sarm1 does 
not affect focal damage resolution by macrophages, which are recruited to the wound 
independently of Schwann cells. We did notice discrete and highly mobile axon fragments 
that were not associated to EGFP(+) cells in WT and Erbb2-/- zebrafish but not in Sarm1-
deficient fish. This observation suggests that loss of Sarm1 does not affect the recruitment 
and the phagocytic activity of macrophages (Tian et al., 2020).  
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Figure 4.10 Loss of Sarm1 does not impair the recruitment of macrophages to injury axons. A) 
Images showing the time lapse imaging of Tg[SILL:mCherry; mfap4:EGFP-CAAX] after severing. The 
arrows indicate macrophages in the severed WT axons. The arrowheads indicate macrophages in the 
severed Sarm1-deficient axons. The asterisks indicate macrophages surround and engulf the injury 
axons in Erbb2-/-. B) Quantification of the number of macrophages recruited to the injury site and 
adjacent axon segments. C) Quantification of the time macrophages interact with axon segments. D) 
Quantification of the size of debris within macrophages. one-way ANOVA was conducted firstly, then 
the T-test was performed between two individual group. E) Time lapse images showing macrophages 
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were recruited into the fragment axons which were induced by ratTRPV1/Capsaicin (modified from 
Tian et al., 2020). 
4.11 Loss of Sarm1 protects Schwann cells against chemotoxicity 
Chemotherapeutic agents invariably cause peripheral neuropathy in clinical trials, leading 
to permanent neuronal dysfunction (Cavaletti et al., 2011; Fukuda et al., 2017). Previous 
studies have revealed that the denervated Schwann cells become susceptible to 
chemotoxicity (Diezi et al., 2013). Therefore, I hypothesized that the protracted 
maintenance of severed axons in Sarm1-/- zebrafish might counteract glial vulnerability to 
chemotoxicity. To test this possibility, I treated WT and Sarm1-deficient zebrafish with 
several chemical compounds that are under clinical trials or that are currently used as first-
line treatment for common cancers in humans. First, I used 10-Hydroxycamptothecin (10-
HCT), which is extremely toxic to denervated glia in zebrafish (Bremer et al., 2017), and 
counted Schwann cells using the fluorescence transgenic marker Tg[gSAGFF202A; 
UAS:EGFP]. This marker is ideal for the experiment because the intensity of green 
fluorescence does not change in denervated Schwann cells and, therefore, it is independent 
of the maturity of the glia. Specifically, the Tg[gSAGFF202A; UAS:EGFP; 
SILL:mCherry] and Tg[gSAGFF202A; UAS:EGFP; SILL:mCherry; Sarm1-/-] samples 
were collected at 4 dpf. These samples were separated into five groups, control, 48 hpi, 10-
HCT (48 h), 24 h 10-HCT/hpi and 48 h 10-HCT/hpi. The control and 10-HCT groups were 
the intact samples without axon transection and were exposed to DMSO (1% V/V) or 10-
HCT individually. The groups with hpi (hour-post injury) were the transected samples in 
which all the axons of the posterior lateral-line were severed with laser on one side of the 
fish. The images displayed the axons (red) and Schwann cells (green) in the indicated 
groups (Figure 4.11.1A). With the quantification of the number of Schwann cells, I 
confirmed that the 10-HCT does not affect the Schwann cells associated to viable axons, 
in both WT and Sarm1-/-. However, there was a significant reduction of the number of 
Schwann cells in 10-HCT treated WT zebrafish with axon transection at 24 hpi. With long-
time treatment, the decrease in the number of Schwann cells was more pronounced. By 
contrast, the number of distal Schwann cells was only marginally affected in axon 
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transected Sarm1-/- zebrafish at 24 hpi with 10-HCT treatment specimens, and nearly 
identical to untreated zebrafish (Figure 4.11.1B).  
Platinum-based, taxanes and some alkaloids are effective chemotherapeutic agents used as 
standards-of-care for various malignancies, despite their severe neuropathic effects that 
include glial destruction (Imai et al., 2017). I selected some of these agents including 
oxaliplatin, cisplatin, paclitaxel, docetaxel and vincristine, to test their effect on Schwann 
cells. The 4 dpf Tg[gSAGFF202A; UAS:EGFP; SILL:mCherry] or Tg[gSAGFF202A; 
UAS:EGFP; SILL:mCherry; Sarm1-/-] larvae were divided into the following groups, WT, 
WT sever, Sarm1-/- and Sarm1-/- sever. The sever-related groups were the one-side posterior 
lateral-line transected animals. All the groups were treated with the indicated agent 
respectively. As showed in the graphs, these drugs do not affect the number of Schwann 
cells in intact WT or Sarm1-/-; however, they all invariably killed the Schwann cells of the 
distal segments in the axon transected WT zebrafish. The number of Schwann cells from 
the axon transected WT zebrafish was reduced to almost half of the number of axon intact 
WT ones. In contrast, the number of Schwann cells was not affected in the Sarm1-deficient 
related groups (Figure 4.11.1C-D). Collectively, I found that upon nerve transection, all 
these drugs invariably killed injury-distal Schwann cells in wild-type specimens but not in 
Sarm1-/- zebrafish (Tian et al., 2020).  
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Figure 4.11.1 Loss of Sarm1 protects Schwann cells against chemotoxicity. A) Confocal images 
showing Schwann cells (green) and lateralis sensory axons (red) in a control specimen (in which axons 
were not transected), in a specimen 48 hours after axon transection, and in specimens treated with 10-
HCT (10-Hydroxycamptothecin). Left column is WT and right column shows Sarm1-/-. In all cases, the 
final concentration of 10-HCT was 40 M. Scale bar 100 m. B) Quantification of the Schwann cells 
from A). Data are shown as mean ± SEM. ** means p < 0.01, two-way ANOVA, n = 8 (each group), 
followed by T-test for two individual group.  C) Table for the chemicals used in the experiment. D) 
Quantification of Schwann cells of WT, WT severed, Sarm1-/- and Sarm1-/- severed with the treatment 
of the indicated chemical compounds for 48 hours. Concentrations: Paclitaxel 40 M, Docetaxel 0.1 
M, Oxaliplatin 500 M, Cisplatin 50 M, Vincristine 50 M. Data are shown as mean ± SEM. * means 
p < 0.05; ** means p < 0.01, three-way ANOVA, n = 8 (each group), followed by T-test for two 
individual group (modified from Tian et al., 2020). 
In Sarm1-/- zebrafish, severed axons remained and did not degrade. These non-degradable 
axons could support the Schwann cell against drug exposure. To answer this hypothesis, I 
generated the transgenic line, Tg[SILL:ratTRPV1-tgRFP; gSAGFF202A; UAS:EGFP; 
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sarm1-/-], which enables me to degrade the severed Sarm1-deficient axons with capsaicin. 
In the WT related groups, the number of Schwann cells was significantly decreased in the 
axon transected groups in presence of 10-HCT or Vincristine, as comparing to the axon 
intact groups. By contrast, in the Sarm1-deficient related groups, the number of Schwann 
cell was no statistical difference between the control and the axon severed groups in 
presence of 10-HCT or Vincristine. These results are consistent to the previous conclusion. 
As expected, the numbers of Schwann cells were decreased to around 110 in axon ablated 
Sarm1-deficient larvae in presence of 10-HCT or Vincristine, in which Sarm1-deficient 
axons were forced to fragment by ratTRPV1/capsaicin. This number is significantly less 
than the Sarm1-deficient axons severed groups with the treatment of 10-HCT or 
Vincristine, although it was slightly more than the WT severed groups upon 10-HCT or 
Vincristine treatment (Figure 4.11.2). Taken together, these data indicate that ablation of 
the axons in Sarm1 deficient neurons could attenuate the protection roles of non-degradable 
axons in Schwann cells against chemotoxicity. Importantly, because none of these drugs 
affect Schwann cells associated with intact axons, I conclude that non-degradable axons 
protect Schwann cells from chemical stress (Tian et al., 2020). 
 
Figure 4.11.2 Ablation of Sarm1-deficient axon attenuates the survival of Schwann cells against 
drugs in Sarm1-/- zebrafish. Quantification of Schwann cells of WT, WT severed+10-HCT, WT 
severed+Vincristine groups, and Sarm1-/-, Sarm1-/- severed+10-HCT, Sarm1-/- severed+Vincristine, 
Sarm1-/- severed+TRPV1+10-HCT, Sarm1-/- severed+TRPV1+Vincristine. Data are shown as mean ± 
SEM. * means p < 0.05; ** means p < 0.01, two-way ANOVA, n = 8 (each group) followed by T-test 
for two individual group (modified from Tian et al., 2020). 
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5. Discussion 
Sensory neurons connect sensory receptors, muscles and skin to the central nervous system 
enabling animals to perform the essential activities in daily life (Abraira and Ginty, 2013). 
Chemical stress, chronic metabolic disease, or physical damage from head concussions, 
motor-vehicle and sporting accidents cause neural injury, leading to axon degeneration in 
peripheral and autonomic neuropathies in humans (McKee and Daneshvar, 2015). Nerve 
injury or glial cells loss has a significant negative impact on the quality of life of the 
affected individuals. Understanding the mechanism of axon degeneration and the function 
of its associated glial cells is essential for screening new therapeutic methods to protect 
neuropathy in clinical trials.  
Zebrafish is an ideal vertebrate model for screening the therapeutic agents. In my thesis, I 
address the effect of absence of Sarm1 on axon degeneration and Schwann cells 
systematically and reveal the possibility to block axon degeneration with loss of Sarm1 as 
a target for developing therapeutic applications. Specifically, I have generated Sarm1-/- 
zebrafish, which impede the degeneration of severed axons in the peripheral and central 
nervous systems. The inhibition of axon degeneration was independent of the Schwann 
cells that surround and ensheath the axons in Sarm1-/- zebrafish. Moreover, prevention of 
axon fragmentation was mediated by attenuating the calcium influx in the axoplasm but 
not in mitochondria or the endoplasmic reticulum. Synthetic elevation of the axoplasmic 
calcium could fragment the Sarm1-deficient axons, suggesting that the calcium influx is 
the downstream event in Sarm1 mediated axon degeneration. I also revealed that loss of 
Sarm1 does not affect viability, touch-evoked response, and rheotaxis of zebrafish. The 
electrophysiology tests showed that the physiological activities of sensory neurons were 
normal in the Sarm1-/- zebrafish. Furthermore, non-degradable axons maintain the structure 
of myelin and Schwann cells, which do not repel the regrowth axons in the sensory nervous 
system. The morphology and the myelination capacity of Schwann cells were normal in 
the Sarm1-deficient zebrafish. Intriguingly, I found that loss of Sarm1 enhances the 
resistance of Schwann cells to chemotoxicity, which is dependent on the non-degradable 
axons. Taken together, targeting the Sarm1 is an ideal strategy for developing therapeutic 
applications. 
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Sarm1 is essential for the degeneration of severed sensory neurons in zebrafish 
My work reveals that the pro-degenerative protein Sarm1 is functionally conserved from 
invertebrate to vertebrate (Osterloh et al., 2012). Considering that zebrafish is an optimal 
model for high-resolution live imaging (Friedrich et al., 2010), Sarm1-deficient zebrafish 
is a welcome addition for future studies of Sarm1 function in vivo. During my work, I 
generated a Sarm1 knockout zebrafish and performed systematic tests with sensory neurons 
that are ideal for imaging the dynamics of axon degeneration and regeneration (Villegas et 
al., 2012). In the Sarm1-/- zebrafish larvae, the distal segments of the severed axons did not 
degrade demonstrating that Sarm1 is essential for Wallerian axon degeneration. 
Because Sarm1 is well conserved across species, I wondered about the benefit of fast 
axonal degradation to the organism, in particular because some invertebrates that include 
crayfish, roundworm and leech maintain injured axons with no signs of degeneration 
(Frank et al., 1975). Strikingly, the lack of axon degeneration may have been selected 
because severed axon segments in C. elegans reseal to reconstitute the neuronal circuit 
rapidly. This appears to be a very effective strategy to recover neural function with high 
fidelity (Neumann et al., 2015). Yet, axon resealing has not been observed in other species, 
begging the question of why vertebrates do not use a similar mechanism after nerve injury. 
One possibility is that the degradation of severed axons is too fast to enable resealing 
(Gumy et al., 2010). Alternatively, resealing events may have remained hidden owing to 
the technical difficulties associated to imaging axonal behavior in living vertebrates. 
Taking advantage of zebrafish lacking Sarm1 and its amenability for high-resolution 
intravital imaging, I tested whether the protracted maintenance of severed axons allows 
axon-segments resealing. To this end, I developed an approach that uses the 
photoactivatable fluorescent protein Kaede to mark individual sensory neurons and 
unambiguously distinguish proximal and distal axon segments after transection. After 
imaging more than 20 samples, I never observed fusion events between axonal segments. 
Instead, regenerating axons grew past the non-degradable distal segments to reinnervate 
peripheral synaptic targets. The regenerative ability of sensory axons was not affected in 
Sarm1-/- zebrafish.  
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Loss of Sarm1 attenuates the axoplasmic calcium influx but not mitochondrial or ER 
calcium uptake 
During Wallerian axon degeneration, the cytoskeleton loses its integrity. Ca2+ influx during 
axon fragmentation activates Calpain to cleave the microtubule-associated components and 
axonal neurofilament (Johnson et al., 1991). Previous studies have shown that knockdown 
Sarm1 in cultured neurons attenuate calcium influx (Summers et al., 2014) (Loreto et al., 
2015). To understand the role of Ca2+ in Sarm1-mediated axon fragmentation, I expressed 
a genetically-encoded fluorescent calcium indicator in sensory neurons of normal and 
Sarm1-deficient embryos to monitor axoplasmic calcium before and after severing. My 
results indicate that calcium influx is blocked in Sarm1-deficient axons transected with a 
laser beam. By contrast, a strong calcium influx preceding axonal fragmentation occurs in 
the wild-type specimens. Following this finding, I enforced calcium influx in Sarm1-
deficient axons using a chemogenetic approach (Chen et al., 2016), which readily induced 
the degradation of Sarm1-deficient axons.  
Increasing the threshold of mitochondrial Ca2+ release can limit white matter loss in 
traumatic brain injury and temporarily delay axon degeneration for up to 4 hours after 
axotomy (Barrientos et al., 2011; Büki et al., 1999). In addition, calcium release from 
axonal endoplasmic reticulum (ER) contributes to axonal degeneration in ex vivo and in 
vitro mouse and rat model systems (Villegas et al., 2014). This raises the question of what 
are the activities of mitochondrial and ER calcium in Sarm1-deficient axons after severing. 
My results show that the calcium influx in mitochondria and ER are enhanced after axon 
transection in wild type and Sarm1-/- zebrafish, suggesting that loss of Sarm1 inhibits axon 
degeneration by attenuating the axoplasmic calcium influx but not calcium uptake by 
mitochondria or the ER. 
Transected sensory neurons recover functionally in Sarm1-/- zebrafish 
Functional recovery from injury is important for the nervous system, which includes re-
innervation of sensory receptors by regenerating axons and restoration of sensory function 
after circuit repair (Graciarena et al., 2014). In my thesis, I use behavioral performance of 
zebrafish to evaluate the function of sensory neurons (Chiu and Prober, 2013; Sztal et al., 
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2016). Specifically, I conducted the experiments of touch-evoked response and rheotaxis 
with wild type and Sarm1-deficient larvae. The results show that the acceleration and 
swimming distance of touch-evoked response and the performance of rheotaxis were not 
significantly different between wild type and Sarm1-/- zebrafish. In addition, the 
electrophysiological results showed that spontaneous and evoked neuronal activities of 
afferent neurons are normal in Sarm1-/- samples, compared to the wild type siblings. These 
results indicate that loss of Sarm1 does not impair the electrophysiology activities of 
sensory neurons and the behavioral performance of animals. 
The rheotaxis was eliminated in the unilateral lateral line transected larvae (Oteiza et al., 
2017). Thus, I assessed the impact of loss of Wallerian axon degeneration on sensorimotor 
recovery. The rheotaxis tests were conducted on the one-side lateral-line transected animals 
(one day and three days after transection). My data show that the performance of rheotaxis 
was severely disrupted in wild type and Sarm1-deficient larvae after severing the lateral 
line axons, compared to the non-transected ones. However, there was no statistical 
significance between the axon transected wild type and the axon transected Sarm1 deficient 
animals. Furthermore, the quantification showed that the performance of rheotaxis rom 
three-days recovery groups (wild type and Sarm1 deficient) were better than the one-day 
transected ones, but it did not recover to the level of intact animals. However, the 
performance of rheotaxis after three-days recovery was not statistically different in wild 
type compared to Sarm1 deficient animals. Taken together, my work demonstrates that 
maintenance of non-degradable axonal fragments has no detrimental effect on the repair of 
sensory circuit in zebrafish. The sensorimotor recovery is not contingent upon the speed of 
clearing severed axons, revealing that the axonal destructive and nerve reconstructive 
processes occur in parallel.  
Sarm1 deficiency delays the remyelination of regenerative axons after injury 
Glial Schwann cells wrap the axons and support myelin to maintain the axons fasciculation 
and insulation with the outside environment. If Schwann cells migration is impeded, 
posterior lateral-line sensory axons cannot grow normally (Lyons et al., 2005). Upon nerve 
injury, Schwann cells help regrowing axons negotiate the injury gap (Glenn and Talbot, 
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2013). In addition, Schwann cells also dictate the onset and timing of axon fragmentation 
after injury (Wong et al., 2017).  
My data show that the Schwann cells adjacent to nerve injury in Sarm1-deficient zebrafish 
behave dramatically differently than those of wild-type specimens. Specifically, Schwann 
cells in Sarm1-/- zebrafish do not migrate or extend projections to bridge the gap in the glial 
scaffold, indicating that these cells do sense missing intercellular contacts or glial 
discontinuity but they do not migrate to the injury site quickly. In wild-type specimens, 
however, I observed that filopodia-like structures emerged from Schwann cells at both 
sides of the injury in wild-type animals, suggesting that repair-inducing signals are likely 
diffusible, affecting glial cells independently of their association with axons. It remains to 
be determined whether the source of such signals is the degrading axons, the denervated 
Schwann cells, or other cells that are recruited to the wound. 
Furthermore, my data reveal that loss of Sarm1 does not attenuate the calcium influx in 
Schwann cell upon stimulation. The GCaMP7a labeled Schwann cells had a dramatic 
calcium influx upon laser ablation in both wild type and Sarm1-/- zebrafish larvae. In 
addition, the immunostaining and live imaging results show that the myelin and the 
structure between axons and Schwann cells are maintained in the distal part of severed 
neurons in Sarm1-deficient specimens, suggesting that non-degradable axons may 
facilitate Schwann cells to maintain the myelin and the interactive structure of axons and 
SCs after nerve injury. Moreover, my findings show that the process of remyelination is 
slightly delayed in Sarm1-deficient zebrafish. Next, my data demonstrate that severed 
axons do not fragment in the Erbb2 and Sarm1 double knockouts that are lack of Schwann 
cells in the lateral-line, indicating that the non-degradable axons in Sarm1-/- zebrafish were 
independent of Schwann cells. Taken together, these results reveal that severed Sarm1-
dificient sensory axons are maintained independently of Schwann cells, and that the non-
degradable axons do not repel the remyelination of the regenerative axons.  
Macrophages are recruited to the injured axons in Sarm1-deficient zebrafish  
Macrophages are involved in clearing the debris of axon and myelin (Bendszus and Stoll, 
2003). The recent published work indicated that Sarm1 functions in the neuronal immune 
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response through the JNK-c-Jun signaling pathway. Inhibition of one component of this 
signaling pathway could effectively abolish the recruitment of immune cells to injury 
afflicted neural tissues (Wang et al., 2018). Yet, there is no direct evidence for possible 
defects of the recruitment of immune cells in vivo in Sarm1-deficient animals. With the 
advantage of transparent zebrafish larva, I imaged the movement of macrophages in 
response to axon injury with high-resolution microscopy. My data show that macrophages 
moved to the injury axons to engulf and to clean the axon debris in wild type zebrafish. 
Strikingly, in Sarm1-/- zebrafish, the macrophages were recruited to the distal part of the 
axons from the far- side to the transected site. They were moving along the axons and 
stayed with the axons, suggesting that these macrophages acted as the surveillances in the 
transected Sarm1-deficient axons. When macrophages were moving along the non-
degradable axons in Sarm1-/- zebrafish, they preferred to stay and surround the bulbs which 
were detaching from the entire axons. In sum, loss of Sarm1 does not impair the recruitment 
of macrophages in the zebrafish after nerve injury. Instead, the macrophages act as the 
surveillance in the Sarm1-/- zebrafish larvae. Furthermore, the phagocytic activity of 
macrophages was not impaired in Sarm1-/- zebrafish. My data supply the direct in vivo live 
imaging of the macrophages in response to axon fragmentation in Sarm1 deficient animals. 
Non-degradable axons maintain and protect the Schwann cells against chemotoxicity 
in Sarm1-/- zebrafish 
Many chemotherapeutic agents invariably cause peripheral neuropathy, leading to 
permanent neuronal dysfunction in clinical trials (Starobova and Vetter, 2017). Previous 
studies have revealed that Schwann cells become strongly susceptible to chemotoxicity 
under denervation  (Diezi et al., 2013). In zebrafish, axons and Schwann cells could be 
easily imaged with high-resolution microscope because of the transparence of fish and 
superficial localization of lateral-line nerves (Xiao et al., 2015a). It enabled me to test the 
effect of chemicals on axonal degeneration, regeneration, and Schwann cells survival in 
live animals. 10-HCT has been shown to reduce integrity of denervated Schwann cell 
(Bremer et al., 2017), and platinum based agents, taxanes and some alkaloids are effective 
chemotherapeutic agents used as standards-of-care for various human malignancies, 
despite their severe neuropathic effects that include glial destruction (Imai et al., 2017). In 
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my thesis, I found the number of Schwann cells decreased dramatically with the treatment 
of 10-HCT and chemotherapy agents, such as Paclitaxel, Docetaxel, Oxaliplatin, Cisplatin, 
and Vincristine, in axonal transection wild type animals; however, the same doses of agents 
did not influence the number of Schwann cells in the axon intact wild type animals. The 
results suggest that nerve injury enhances the sensitivity of Schwann cells to chemotherapy 
agents. In contrast, the number of Schwann cells was maintained in the presence of 
chemicals in the Sarm1 deficient animals, even when the axons were transected. The non-
degradable axons which sustain the structure between axons and Schwann cells and the 
myelination of transected axons could result in the protective effect. Then, I used the 
chemogenetic approach to fragment Sarm1-deficient axons before chemicals incubation. 
The results show that the number of Schwann cells is reduced in presence of chemicals 
when the Sarm1-deficient axons are forced to fragment.  
Loss of Sarm1 improves functional recovery after vincristine-mediated neurotoxicity, and 
traumatic brain injury in mice (Geisler et al., 2016; Henninger et al., 2016). However, the 
therapeutic potential of blocking axon degeneration by inhibiting Sarm1 systemically 
remains uncertain. My data demonstrated that chronic and systemic loss of Sarm1 is 
compatible with zebrafish viability and sensorineural function. Interestingly, data from the 
Genetic Testing Registry illustrate that Sarm1 variants in humans have only been 
associated to congenital defect of folate absorption (Landrum et al., 2013). Dietary 
reduction of folates can prevent the appearance of symptoms of folate absorption defect. 
Therefore, in zebrafish, mouse and humans, Sarm1 appears to be a non-essential protein 
whose deficit is associated to mild conditions. As a discrete hierarchical factor in axon 
degeneration, Sarm1 is an ideal target for pharmacological interventions.  
Conclusion 
I firstly generated Sarm1 deficient zebrafish by CRISPR-mediated genome engineering 
tool. With this knock-out zebrafish, I provide a comprehensive understanding the function 
of Sarm1 from the sub-cellular to the organismal level. To validate these studies, I used 
genetic manipulations of sensory neurons and several transgenic fluorescent sensors in 
neurons and Schwann cells to characterize the consequences of Sarm1 loss.  
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In brief, I reveal that loss of Sarm1 is well tolerated by zebrafish. Sarm1-deficient zebrafish 
are viable, and perform touch-evoked response and rheotaxis normally. Axon degeneration 
is blocked in the Sarm1-deficient zebrafish, but Sarm1-deficient regenerative axons 
fasciculate and regain synaptic connectivity, suggesting that absence of competition 
between non-degradable axon fragments and re-growing fibers, and that neuronal-circuit 
repair is not contingent upon rapid clearance of damaged axons. The striking resealing of 
severed axons observed in C. elegans is not a general feature of the nervous system, even 
when severed axons are non-degradable.  
In addition, I show with unprecedented spatial and temporal detail by intravital microscopy 
the response of Schwann cells to neuronal damage and axonal regeneration in normal 
condition and when Wallerian axon degeneration is disrupted. The results deepen our 
understanding of the cellular environment that enables Schwann cell reprogramming upon 
nerve damage. Furthermore, the protracted maintenance of transected axons dramatically 
improves Schwann-cell tolerance to chemotoxicity after nerve injury. Meanwhile, loss of 
Sarm1 does not affect the recruitment of macrophages to the injured axons.  
Importantly, these data strongly support the idea that direct interventions to inhibit axon 
degradation systemically are promising strategies to reduce chronic consequences of nerve 
injury. Because TIR domain dimerization is necessary and sufficient to degrade NAD+, it 
renders Sarm1 amenable to inhibition by small molecules, as it has been demonstrated for 
the TIR domain of TLR2. Thus, the findings in this work encourage the development of 
Sarm1 inhibitors for therapeutic applications. 
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